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While amyloidogenic proteins are commonly associated with human diseases 
such as Alzheimer’s and Parkinson’s disease, it is intriguing that amyloid fibrils also 
are utilized for essential biological processes.  A key question then is why many 
amyloids are harmful whereas some serve essential functional roles.  To begin to 
address this question, the environmental factors regulating the conformational 
changes in the Parkinson’s disease-related protein, α-synuclein (α-syn), and a critical 
polypeptide fragment, the repeat domain (RPT) of Pmel17, the protein required for 
melanin formation are examined.   
The role of membranes in modulating α-syn conformation is investigated 
because membranes are ubiquitous in vivo and affect α-syn aggregation in vitro.  
Using single tryptophan-containing α-syn variants (F4W, Y39W, F94W, Y125W) as 
site-specific fluorescent probes, distinct phospholipid vesicle and SDS micelle 
  
interactions have been identified and membrane binding equilibria measured.  The 
role of specific N-terminal residues in membrane binding also has been assessed.  
Specifically, environments of the highly sensitive Trp4 probe in α-syn polypeptide 
fragments (residues: 1 – 4, 1 – 6, 1 – 10, and 1 – 15) upon membrane binding were 
characterized using steady-state fluorescence and time-resolved anisotropy.  The 
penetration depths of α-syn and N-terminal peptides into the lipid bilayer also were 
determined using brominated lipids as heavy-atom quenchers.  To simultaneously 
monitor α-syn and bilayer structure, neutron reflectometry (NR) and a sparsely-
tethered bilayer lipid membrane (stBLM) were employed.  Using NR and an stBLM, 
α-syn concentration dependent effects on both protein structure and membrane 
properties were measured.   
To begin to address biophysical and biochemical differences between 
pathological and functional amyloid, a systematic investigation of the effects of 
solution pH (4→7) on RPT aggregation was performed since melanosomes, acidic 
organelles where Pmel17 fibrils are formed, change pH during maturation.  Using 
intrinsic tryptophan fluorescence, circular dichroism spectroscopy, and transmission 
electron microscopy, local, secondary, and fibril morphological structure were 
monitored, respectively.  Notably, RPT fibril morphology can be transformed directly 
by changing solution pH, suggesting that pH is a natural regulatory mechanism for 
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Chapter 1: Amyloid Proteins and Biophysical Probes of 
Their Interactions with Biomembranes*  
 
 
1.1  Amyloid Proteins in Disease and Function 
Knowledge of three-dimensional protein structure is vital given the intimate 
connection between protein structure and function.  Though most proteins adopt 
stable native structures, many can undergo large structural rearrangements under 
certain solution conditions.  Among the latter are proteins which form amyloid.  
Amyloid is comprised of proteinacious fibrillar aggregates1 that both bind fibril 
specific dyes such as thioflavin T (ThT)2 and congo red3 and exhibit a characteristic 
cross β-sheet x-ray diffraction pattern.4  Morphologically, amyloid fibrils are usually 
unbranched filaments ~ 0.1 – 100 μm in length and ~ 10 nm in width.5  At the 
molecular level, fibrils are comprised of individual β-strands running perpendicular to 
the long fibril axis (backbone hydrogen bonds are parallel to the long axis) that are 
arranged in β-sheets which extend over the length of the fibril.5   
A transmission electron microscopy (TEM) image of fibrils as well as a 
schematic representation of one characteristic amyloid structure, in-register parallel β-
sheets, is provided in Figure 1.1.  In this architecture, β-strands from adjacent stacked 
polypeptides are aligned in-register and parallel.6  Thus, β-sheets run the length of the 
fibril and are stabilized by backbone amide hydrogen bonds that are parallel to the 
long fibril axis.6  Though the in-register parallel β-sheet structure is common to many 
                                                 
*Adapted in part from Pfefferkorn, C. M., Jiang, Z., Lee, J. C., Biophysics of α-synuclein membrane 




pathological amyloids, several other pathological and functional amyloids have 
alternate structures in which adjacent β-strands have different arrangements.6     
 
Figure 1.1:  Macroscopic morphology and molecular organization of amyloid fibrils.  
(A)  Transmission electron microscopy image of negatively stained (0.5% uranyl 
acetate) amyloid fibrils comprised of aggregated α-synuclein protein.  (B)  Schematic 
representation of a parallel in-register β-sheet amyloid fibril structure in which 
individual β-strands run perpendicular to the long axis with adjacent β-strands 
forming β-sheets that extend the length of the fibril. 
 
In general, amyloid formation processes exhibit sigmoidal kinetic behavior 
characterized by a lag, growth, and stationary phase (Figure 1.2).7  Though several 
models have been proposed to describe amyloid formation processes, one prevalent 
model is based on nucleation-dependent assembly.7  In this model, monomeric 
proteins interact during the lag phase until a thermodynamically unfavorable 
oligomeric species, called a nucleus or seed, is formed.7  A growth phase then 
commences which is characterized by rapid fibril formation resulting from 
monomeric proteins templating onto the nucleus.7  Once equilibrium between the 
monomeric and fibrillar state is reached, fibril growth slows and eventually ceases 
indicating the beginning of the stationary phase.  A nucleation-dependent mechanism 











seeds, can mitigate or even abolish the lag phase.7  Among the most common 
methods to monitor amyloid formation kinetics are ThT fluorescence, laser light 
scattering, and circular dichroism (CD) spectroscopy in which fibril, macroscopic 
aggregate, and secondary structural content are measured, respectively.  
 
Figure 1.2  Amyloid formation kinetics.  Amyloid formation kinetics for the repeat 
domain (RPT) of Pmel17 with lag, growth, and stationary phases indicated.  Solid 
line is a sigmoidal fit to the data.  In this example, aggregation kinetics are monitored 
by laser light scattering.  A simplified schematic representation of the protein species 
present during each phase is provided for reference.   
 
Amyloid formation has been long associated with specific human diseases 
such as Alzheimer’s and Parkinson’s disease.  In these prevalent neurodegenerative 
diseases, a pathological hallmark is the presence of brain plaques comprised of 
aggregated protein.  In the case of Alzheimer’s and Parkinson’s disease, amyloid 
brain deposits are composed primarily of amyloid-β (Aβ) and α-synuclein (α-syn) 
proteins, respectively.  However, in the last ten years, the amyloid fold has also been 
discovered to play a role in essential biological processes.8-12  For example, fibrils 






















melanin deposition.13  A representative list of disease-related and functional amyloids 
(i.e. amyloids involved in essential biological processes) along with their respective 
biological involvement is provided in Table 1.1.   




Amyloid β Alzheimer’s  
Apolipoprotein AI Hereditary amyloidosis 
Ataxins Spinocerebellar ataxias 
Atrial natriuretic factor Artial amyloid 
β2-Microglobulin Hemodialysis-related amyloidosis 
γ-Crystallins Cataract 
Gelsolin Hereditary amyloidosis 
Huntingtin Huntington’s 
Islet amyloid polypeptide Type 2 diabetes 
Lysozyme Hereditary amyloidosis 
Medin Amyloid in medial layer of arteries 
Prion Spongiform encephalopathies 
Pro-calcitonin  Medullary carcinoma of the thyroid 
Serum amyloid A Secondary systemic amyloidosis 
Superoxide dismutase Amyotrophic lateral sclerosis 
Tau Dementia with Parkinsonism 
Transthyretin 
Senile systemic amyloidosis/familial 
amyloidotic polyneuropathy 
Functional Amyloidsa 
Chaplins (bacteria) Spore surface protein 
Chorion proteins (insects and fish) Protective structure of eggshell  
CsgA and CsgB (bacteria) Biofilm formation/surface adhesion 
FapC (bacteria) Biofilm component 
Fungal adhesions (fungus) Cell adhesion 
HET-s (fungus) Regulation of heterokaryon formation 
HpaG (bacteria) Plant pathogen virulence factor 
Hydrophobins (fungus) Form amphipathic surface layer 
Merozoite surface protein 2; MSP2 (protozoa) Implicated in erythrocyte invasion 
Microcin E492; Mcc (bacteriocin) Regulate Mcc toxicity  
Neuron-specific isoform of CPEB, prion           
(marine snail) 
Long-term maintenance of synaptic 
changes associated with memory storage 
Nsp1 (yeast) Control nucleoplasmic mixing at nuclear pore 
Peptide hormones (human) Control hormone release 
Pmel17 (human) Melanin scaffold 
Spidroin (spider) To form the silk fibers of the web 
Sup35 (yeast) Regulation of stop-codon read-through 
TasA (bacteria) Biofilm component 
Type 1 antifreeze protein; AFP (flat fish) Ice inhibition 
Ure2p (yeast) Regulation of nitrogen catabolism 
 
a Species in which the functional amyloid is found is denoted in parenthesis  
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One central question is why functional amyloids are benign whereas their 
disease-related counterparts are harmful.  A partial answer may be related to how 
efficiently cellular machinery and/or processes can regulate amyloid formation and 
degradation.  Furthermore, it is plausible that disease-related amyloidogenic proteins 
adopt cytotoxic conformationally altered (misfolded) and fibrillar precursors such as 
spheres and annuli,14 whereas functional amyloid proteins do not.  Figure 1.3 
provides a schematic representation depicting pathways through which an 
unfolded/misfolded conformer can be refolded, degraded, or converted to amyloid.  
Specifically, an unfolded or misfolded monomer can be degraded by the ubiquitin 
proteasome system (UPS) or the lysosome as well as be folded refolded by 
chaperones.  If not degraded or folded, soluble protein aggregates and amyloid may 
form.  Notably, unfolded or misfolded amyloid precursors that bind to biomembranes 







Figure 1.3  Schematic representation depicting pathways through which an 
unfolded/misfolded conformer can be either refolded, degraded, or converted to 
amyloid.  The formation/interaction of membrane bound oligomers with membranes 
is also depicted. 
 
1.2  The Role of Membranes in Amyloid Formation  
To adopt amyloid structure, proteins must either partially unfold from the 
native globular state or undergo a conformational change from the unstructured 
state.15  For this reason, it is of utmost importance to elucidate the involvement of 
biomolecules that modulate protein structure by performing detailed studies of 
amyloid formation kinetics under different solution conditions.  The role of 
membranes is of particular interest because membranes affect the protein-folding 
landscape16 and are ubiquitous in vivo.  Indeed, it is now well established that 

















One popular supposition for why membranes promote amyloid formation is 
that the membrane serves as a 2-dimensional (2D) folding template.17  While in 
solution the average distance between proteins is proportional to the cube root of the 
total protein concentration, at the 2D interface this distance is proportional to the 
square root of the total protein resulting in significantly decreased distances between 
nearest neighbors.17,18  Because aggregation requires specific protein-protein 
interactions, an effective local concentration increase at the membrane surface would 
enhance these contacts and subsequently aggregation.  Moreover, in cases where the 
stability of the native state is reduced upon membrane binding, the critical 
concentration for aggregation may be lowered at the membrane interface further 
promoting aggregation.17  It is noteworthy that in addition to effective protein 
concentration increases, protein-protein interactions would also be modulated by the 
different relative ion concentrations19 and diffusion20,21 at the membrane interface.       
Another explanation for why protein aggregation could be stimulated by the 
presence of membranes is that in the membrane-bound state, key hydrophobic 
residues, otherwise protected in the native state, could be exposed.  Substantial 
evidence has been collected suggesting that in particular, partially helical 
intermediate structures may be important in amyloid formation.15  For example, it was 
found that in the Aβ peptide a transient increase in α-helical content precedes β-sheet 
formation and that the kinetics of α-helical formation is directly correlated to fibril 
formation.22,23  Other examples in which partially helical intermediates have been 
implicated include α-syn,24 islet amyloid polypeptide,25 tau,26 and medin.27     
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1.3  Biophysical Probes of Membrane Protein Structure 
To elucidate the molecular basis of protein aggregation in the presence of 
membranes, techniques to probe membrane-bound protein structure and the protein-
membrane interface are required.  While recent advances in experimental techniques 
and purification procedures have facilitated the study of more membrane-protein 
systems than ever before,28 preparation of samples that retain functionally relevant 
structures after purification and/or crystallization remains a challenge in most cases.  
As such, various complementary biophysical approaches (Figure 1.4), in addition to 
conventional structural techniques, such as solution-state nuclear magnetic resonance 
(NMR) spectroscopy29,30 and electron and x-ray crystallography31,32 have been 
employed to study membrane protein secondary and tertiary structure as well as the 
membrane-protein interface. 
 




Far UV circular dichroism
Fourier transform infrared












Fluorescence anisotropy, Fluorescence quenching, Electron 
paramagnetic resonance, Neutron reflectometry
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1.3.1  Secondary Structure  
Among the most common biophysical probes of secondary structure are 
circular dichroism (CD), Fourier transform infrared (FTIR), and ultraviolet 
resonance-Raman (UVRR) spectroscopies.  CD spectroscopy, in which the difference 
in left- and right-handed circularly polarized light absorption is measured, allows for 
direct quantitation of secondary structural content because alignments of polypeptide 
amide bonds (i.e. specific alignments corresponding to α-helical, β-sheet, or random-
coil polypeptide conformations) induce distinct UV absorption bands.33,34   
In cases where measurements of solid and/or UV opaque samples are 
required, FTIR can be used since the absorption bands corresponding to the amide 
bond stretching frequencies are also modulated by polypeptide secondary 
structure.35,36  Though less widely applied, an emerging technique, UVRR, in which 
inelastic UV light scattering is measured, can also be employed to monitor secondary 
structural changes in proteins in presence of lipid membranes.37  One advantage of 
UVRR over CD and FTIR is that by tuning into (resonance) the aromatic absorption 
bands, one can obtain high sensitivity to Tyr and Trp residues and hence the ability to 
characterize site-specific environments and structure.37,38  
1.3.2  Tertiary Structure  
Though solution-state NMR is a widely used protein structural determination 
technique, high concentrations of isotopically labeled reconstituted protein is needed 
and the membrane bound protein must isotropically reorient on NMR relevant time 
scales.  The latter point has particularly limited the use of solution-state NMR in the 
structural determination of membrane proteins because protein resonances simply 
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disappear upon association with the comparatively large phospholipid vesicles.30  
However, this NMR signal disappearance can be useful for identifying residues that 
are membrane bound.39  Alternately, by using small membrane mimics such as 
micelles, solution-state NMR has been quite successful in producing structural 
models.17,40 
To address the problem of slow protein reorientation at the membrane 
interface, oriented and magic angle spinning solid-state NMR methods can be 
employed.  In oriented solid-state NMR, membranes are aligned such that anisotropy 
inherent in chemical shifts, quadrupolar interactions, and dipolar couplings can be 
used to extract information regarding the tilt and pitch of helices interacting with 
membranes.29,41  When alignment of the membrane is not feasible, magic angle 
spinning solid-state NMR is particularly useful.  In this technique, the sample spins at 
an angle with respect to the static magnetic field in such a way that signals are 
significantly enhanced.41,42  Using magic angle solid-state NMR, structural 
information on membrane-bound proteins can be extracted including distance and 
backbone dihedral angle restraints.       
Distance constraints between specific residues in soluble or membrane bound 
proteins can be determined by exploiting Förster resonance energy transfer (FRET) 
and double electron electron resonance (DEER).  In FRET, the energy transfer 
between fluorescent donor (D) and energy acceptor (A) molecules can be determined 
since the energy transfer rate, or efficiency, depends on the inverse sixth power of the 
distance between the D and A.43-46  By monitoring fluorescence from proteins 
containing D and A molecules in the presence and absence of membranes, changes in 
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pairwise distances can be extracted.47,48  In DEER, the coupling between two residues 
tagged with electron spin labels (typically between nitroxide spin labels) can be 
measured and correlated to distance.49 
1.3.3  The Membrane-protein Interface  
Several fluorescence methods can be utilized to probe site-specific protein 
interactions with the membrane.  Since many intrinsic and extrinsic fluorophores are 
highly sensitive to local environment, changes in fluorescence features (e.g. mean 
wavelength and quantum yield (QY)), can inform on membrane binding.  For 
example, upon interaction with the hydrophobic membrane core, tryptophan 
fluorescence can shift by as much as 25 − 28 nm.50,51  In addition to membrane 
binding, differences in steady-state fluorescence QY also can reflect interactions with 
specific charged lipid headgroups or amino acid (aa) side chains.52  Moreover, 
because QY is greatly reduced in the presence of heavy-atom quenchers such as 
iodide or bromine, site-specific solvent/membrane exposure can be determined.53-56  
Using fluorescence quenching, hydrophobic α-helical regions for several 
transmembrane peptides have been identified.57   
Similar determination of site-specific solvent or lipid exposure can be 
accomplished using electron paramagnetic resonance (EPR).  In EPR, the interaction 
of unpaired electron spins in an external magnetic field is monitored.  Though most 
systems do not contain unpaired electrons, EPR spin labels can be incorporated to 
determine site-specific information on molecular environment.  For example, EPR 
signals can distinguish between a spin label in the O2 rich membrane, or the aqueous 
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phase by using an extrinsic probe such as nickel ethylenediamine-N-N'-diacetic acid 
(NiEDDA).58     
Fluorescence anisotropy is another method informing on site-specific 
environments and membrane association.  In fluorescence anisotropy, the extent of 
reorientation of the fluorophore between polarized excitation and emission planes is 
measured.  Since the degree of reorientation of the fluorescence emission depends the  
rotational diffusion of the fluorophore, information regarding the size and shape of 
the diffusing molecule and the solvent viscosity can be extracted.59  Anisotropy 
measurements are particularly useful in the study of membrane associating proteins, 
because both solvent viscosity and size change upon membrane binding.  
Furthermore, membrane-induced protein oligomerization and aggregation can be 
monitored using this technique.   
One promising emerging technique for the study of protein-membrane 
interactions is neutron reflectometry (NR).60-62  In this technique, neutrons impinge 
on a horizontally oriented sample at small angles (< 5°) and scattered neutrons are 
measured.  Using NR, the structure of deposited materials up to several hundred nm 
from the surface normal can be measured with angstrom level resolution.63  The 
recent development of a sparsely-tethered solid-supported sparsely-tethered bilayer 
lipid membrane (stBLM) for use in NR has enabled simultaneous measurement of 
both membrane properties (e.g. membrane thickness) as well membrane-bound 
protein structure.64  NR and a stBLM has recently been employed to study the effect 
of Aβ oligomers on membrane properties62 and the structure of functional 
Staphylococcus aureus α-hemolysin channels.61 
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1.4  Biophysical Techniques Used to Study the α-Synuclein-membrane Interface 
and Pmel17 Aggregation  
 In this work, several of the aforementioned biophysical techniques have been 
employed to elucidate the site-specific interactions of α-syn with model membranes 
and the conformational changes in the repeat domain (RPT) of Pmel17.  One primary 
technique used is site-specific fluorescence.  In particular, the exquisite 
environmental sensitivity of intrinsic Trp fluorescence is exploited to determine α-
syn-membrane interaction sites and to generate equilibrium protein-phospholipid 
vesicle binding curves.  Site-specific Trp fluorescence also is used to determine 
conformational changes in RPT as a function of its aggregation state and pH solution 
condition.   
Time-resolved Trp fluorescence provides additional insights into 
conformational heterogeneity of α-syn in the presence of phospholipid vesicles.  This 
technique is also used to determine if specific α-syn peptide fragments bind to 
phospholipid vesicles and to report on RPT oligomerization state.  Fluorescence 
measurements in the presence of vesicles containing bromine allow for the site-
specific determination of α-syn insertion into the bilayer.  Another fluorescence 
quencher, acrylamide, is used to determine the level of solvent exposure of the Trp 
side chain in RPT under different solution conditions.  Fluorescence correlation 
spectroscopy, a single molecule technique in which the concentration and diffusion of 
a fluorescently tagged species can be quantified, has also been used to determine α-
syn-planar membrane bilayer binding equilibrium. 
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In addition to fluorescence spectroscopic methods, various additional 
complementary biophysical techniques are used in this work.  One of these 
techniques is CD spectroscopy.  Specifically, CD reports on membrane induced 
random-coil-to-α-helical transitions in α-syn as well as the secondary structures 
associated with RPT oligomerization and aggregation states.  Solution-state NMR is 
employed as an independent assay of α-syn membrane interaction.  TEM has been 
particularly useful in assessing macroscopic aggregate formation in both α-syn and 
RPT.  Finally, the use of the emerging biophysical technique NR as a dual probe of 
membrane-bound α-syn and bilayer membrane structure is described.    
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Chapter 2:  α-Synuclein Is a Membrane Protein Associated 
with Parkinson’s Disease*  
 
2.1  α-Synuclein and Parkinson’s Disease 
Parkinson’s disease (PD) is a prevalent age-related neurodegenerative disorder 
with an estimated 1.5% lifetime risk for developing the disease.65  PD patients exhibit 
resting tremors, bradykinesia, rigidity, and impaired balance caused by the loss of 
dopamine-producing cells in a midbrain region called the substantia nigra.65  The 
origin of dopaminergic cell death is unknown; however, biochemical, histological, 
and genetic studies have implicated a neuronal protein, α-syn, in PD pathogenesis.  
Particularly, α-syn is the primary component of intracellular proteinacious aggregates 
called Lewy bodies (LBs) and neurites found in PD patients.65  While soluble α-syn is 
characterized as natively unfolded in vitro,66 it is the aggregated β-sheet form 
(amyloid fibrils) that is found in LBs and neurites.8,67  It is clear that it is not simply 
the presence of α-syn that is associated with PD, but also its corresponding 
conformational state.  Protofibrillar (oligomeric) species have also been implicated as 
pathogenic agents;67,68 however, the exact role of α-syn oligomers in cytotoxic and 
aggregation pathways is not clear.  In addition, oligomers of α-syn have been shown 
to both accelerate69 and inhibit α-syn fibril formation.70  It is these features that 
consequently place PD in the category of a protein misfolding disease.8,71   
                                                 
*Adapted in part from Pfefferkorn, C. M., Lee, J. C. Tryptophan probes at the α-synuclein and 
membrane interface, J. Phys. Chem. B 114 (2010) 4615 – 4622. and Pfefferkorn, C. M., Jiang, Z., Lee, 
J. C., Biophysics of α-synuclein membrane interactions, Biochim. Biophys. Acta Biomembr. (2011), 




Further implicating α-syn in PD are genetic findings that link early-onset PD 
to gene triplication72 and duplication73 and three missense mutations (A30P, E46K, 
and A53T).74-76  Moreover, age-related increases in α-syn concentration also are 
observed in nigral brain regions.77   Recent work demonstrates that triple α-, β-, γ-syn 
knockout mice exhibit age-dependent neuronal dysfunction providing further support 
for the tight connection between α-syn and PD.78  
2.2  α-Synuclein Discovery 
The name synuclein (syn) was first given in 1988 to a novel 143 aa protein 
isolated from the presynaptic terminals and nuclei of the nervous tissues of the Pacific 
electric ray, Torpedo californica.79  Two years later, a similar 134 aa phosphorylated 
protein was discovered in bovine brain neuron synapses; however, it was named 
phosphoneuroprotein 14.80,81  In subsequent independent work, a hydrophobic 35 aa 
sequence (termed non-amyloid β component; NAC) was identified in Alzheimer’s 
disease (AD) amyloid plaques whose 140 aa precursor protein was coined NACP, or 
non-amyloid β component precursor protein.82  Yet another group discovered a 
homolog of NACP in zebra finch and called it synelfin.83  Though identified in 
different organisms, all of these proteins are similar in size (134 – 143 aa), do not 
contain Cys or Trp residues, contain imperfect amphipathic aa repeats, and have a 
highly acidic C-terminal domain.83 
Finally, it became clear that synelfin, synuclein, and NACP were homologous 
proteins and thus, designated as α-syn.  The human homolog of phosphoneuroprotein 
14 was called β-syn.84  Subsequently, yet another member of the synuclein family, γ-
syn, was identified in breast cancer tissue.85  Though the synucleins (α, β, and γ) are 
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highly homologous,83,86 and likely share similar biological functions in vivo, it is α-
syn that has gained widespread interest due to its involvement in PD etiology.   
To pinpoint a definitive role of α-syn, numerous in vivo and in vitro studies 
were conducted.  A role of α-syn in membrane related cellular function, specifically 
in coordinating nuclear and synaptic events, was first predicted based on the 
localization of synuclein from the Torpedo californica.79  Studies on canary α-syn 
further demonstrated a connection between α-syn expression and synaptic plasticity 
during learning.83  Direct evidence for localization of α-syn near synaptic vesicles 
was later achieved via immunogold labeling of α-syn and visualization by electron 
microscopy.87 
Though α-syn knockout mice do not exhibit noticeable phenotypic changes as 
compared to wild type (WT) mice,88,89 differences in cells cultured from knockouts,90 
in the level of dopamine release,88,89,91 and in the quantity of the synaptic vesicle 
reserve pool92,93 point toward the involvement of α-syn in synaptic vesicle trafficking.  
Indeed more recent work shows that α-syn is required for the maintenance of 
continuous presynaptic SNARE (sensitive factor attachment protein receptor) 
complex assembly, a complex required for neurotransmission.94  
A correlation between mitochondrial dysfunction and PD95 has also prompted 
significant interest in α-syn interactions with mitochondrial membranes.  Specifically, 
it has been proposed that intracellular acidification resulting from oxidative or 
metabolic stress can induce translocation of α-syn from the cytosol to the surface of 
the mitochondria.96  Using FRET-based reporters, it was shown that the conformation 
of α-syn is indeed altered in the presence of mitochondrial membranes.97 
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2.3  α-Synuclein Primary Structure  
α-Syn primary structure has several distinct characteristics.  One dominating 
feature is that the N-terminal 89 residues contain seven imperfect 11 aa repeats 
(consensus sequence KXKEGV, Fig. 2.1) that are amphipathic in nature.  These 
repeats, which contain charged residues flanked by paired lysine residues at the 
apolar-polar interface (class A2 helix)
98 are also motifs found in AII, CI, CII, and CIII 
exchangeable apolipoproteins.99,100  The central region (residues 61 – 95), or NAC 
region, is composed of nonpolar side-chains and is important for promoting protein 
aggregation.101  In contrast, the C-terminal domain is highly acidic (15 carboxylates), 
does not generally associate with membranes,102,103 or form part of the fibril core.104-




Figure 2.1  α-Synuclein primary structure.  (Top) α-Syn primary amino acid 
sequence with aromatic (cyan), acidic (red), and lysine (blue) residues highlighted 
and the seven imperfect consensus sequence (KXKEGV) repeats underlined.   
(Bottom) Schematic representation of α-syn with amphipathic repeats, non-amyloid β 
component (NAC) region, membrane binding domain, and acidic region in blue, 
cyan, gray, and red, respectively.  The location of the amphiphatic repeats, the 
disease-related mutations, and the membrane binding domain also are denoted. 
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2.4  α-Synuclein Membrane Interactions and Parkinson’s Disease  
Despite a general consensus regarding the participation of α-syn in PD,65,108 
work is still ongoing regarding the role of α-syn-membrane interactions.  One link is 
that the presence of disease-related mutations modulates α-syn membrane binding in 
vitro.109-115  Moreover, as PD is classified as a protein misfolding disease, 8,71 perhaps 
the most compelling biophysical evidence is that the presence of membranes affects 
α-syn secondary structure.116  It is plausible that upon membrane binding, energy 
barriers inhibiting the formation of potentially toxic, oligomeric or β-sheet structures 
are lowered.  Another mechanism, supported by mounting experimental data, is that 
α-syn membrane binding results in membrane instability and/or permeabilization, 
both of which could impact various in vivo processes. 
2.4.1  Effect of Disease-related Mutations on Membrane Binding 
Disparities in the membrane binding properties of WT and PD-related mutant 
α-synucleins were first noted in 1998 when it was reported that WT and A53T bound 
to rat brain vesicles whereas A30P did not.111  Although to varying degrees, 
subsequent studies revealed further disparities between the membrane affinity of WT 
and A30P.  In 2000, Perrin et al. showed using site directed mutagenesis and CD 
spectroscopy that the familial mutants had little (A30P) or no (A53T) effect on lipid 
binding or α-helicity.114  In contrast, using ultracentrifugation, CD spectroscopy, and 
low-angle X-ray diffraction Jo et al. found that A30P was defective in binding while 
A53T almost showed a comparable binding ability to WT α-syn.112  Bussell et al. 
later confirmed that A30P, but not A53T, decreased lipid binding affinity.109     
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Though some inconsistencies between the relative effects of the A30P and 
A53T mutation on membrane binding exist, it is likely that these differences can be 
accounted for by the fact that experiments were performed using model membranes 
of different composition and size and under different solution conditions.  For 
example, in an isothermal calorimetry study, it was shown that A30P shared a similar 
binding affinity to the WT in a gel phase (i.e. DPPC) whereas binding was weaker in 
the liquid crystalline phase (i.e DOPC/DOPG) as compared to WT.113  Moreover, it 
was shown using giant unilamellar vesicles (GUVs), that the A30P protein bound less 
efficiently compared to WT α-syn.115         
Though less research has been conducted on the effects of the E46K mutant 
due to its more recent discovery,76 unlike A30P, the presence of E46K generally 
increases α-syn membrane affinity.110,115  Since α-syn prefers anionic surfaces,116 it is 
likely the introduction of an additional positive charge enhances electrostatic forces 
between the protein and the anionic membrane.  Whether the membrane affinity is 
increased (E46K) or decreased (A30P), it is clear that under certain solution 
conditions the presence of mutations can modulate the equilibrium between solution 
and membrane-bound conformations.  
2.4.2  Membrane Mediated α-Synuclein Oligomer Formation and Aggregation 
It is unclear whether the β-sheet structure found in the LBs of PD patients are 
protective or toxic to cells in the brain; however, substantial evidence show that the 
presence of membranes or membrane mimics can modulate the formation of β-sheets 
in vitro.117-119  One possibility is that the membrane surface facilitates local increases 
in α-syn concentration and therefore, stimulates aggregation.17,120  This reasoning is 
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attractive because it is known that increased α-syn concentration caused by gene 
triplication or duplication leads to early onset PD.72,73   
Notably, α-syn aggregation kinetics are highly dependent on the ratio of 
protein-to-membrane mimic in solution.118,119  This observation is consistent with 
another possibility that membrane binding induces the formation of toxic or 
aggregation-prone oligomers.  This idea first was discussed in the context of CD data 
showing that α-syn aggregation rate is correlated to the level of α-helicity (partial and 
saturating helicity correspond to accelerated or slowed aggregation, 
respectively).118,119  This suggestion that membranes promote oligomer formation is 
corroborated by various other studies.121  For example, EPR data on small unillamelar 
vesicles (SUVs) bound α-syn, reveal a membrane induced dimeric structure.122  In 
another recent report, a trifluoroethanol induced partially helical monomeric species 
of α-syn was characterized and associated with enhanced fibril formation.24  
Interestingly, though disease-related mutants (A30P, E46K, A53T) exhibited similar 
TFE-induced secondary structure, oligomerization rates differed substantially as 
compared to WT protein, bolstering the connection between membranes and PD 
pathogenesis.24   
Substantial experimental data also support a likely prominent role of 
membranes in modulating α-syn oligomerization and/or protein aggregation in vivo.  
In the presence of isolated brain fractions, α-syn was found to aggregate, whereas no 
aggregates were detected in the cytosolic fraction.123  The addition of membrane-
bound α-syn also was found to seed aggregation in the cytosolic fraction.123  
Moreover, chemical cross-linking experiments in cells treated with high 
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concentrations of fatty acids show that α-syn forms dimers and trimers that 
preferentially associate with the phospholipid monolayers surrounding triglyceride-
rich lipid droplets as well as other cellular membranes.124  Interestingly, while the 
PD-related mutant E46K also localized to the lipid droplets and membranes, A30P 
remained cytosolic.    
2.4.3  α-Synuclein Induced Membrane Perturbation  
One mechanism through which amyloidogenic proteins can cause cellular 
dysfunction is by inducing instability in membranes.125-128  In 2001, it was shown that 
protofibrillar α-syn can cause transient permeabilization in anionic membranes and 
thus it was proposed that α-syn could alter calcium flux into the cytosol, 
depolarization of mitochondrial membranes, and/or leakage of intra-vesicular 
neurotransmitter molecules, such as dopamine.129  Further experiments revealed that 
protofibril induced membrane leakage is increased when disease-related mutations 
are present (A30P and A53T).130  
Numerous other studies have since confirmed that indeed various 
conformations of α-syn can cause membrane instability and even pore formation.  For 
example, using atomic force microscopy and vesicle dye leakage assays, it was shown 
that membrane disruption is positively correlated to α-syn membrane affinity and that 
fibrillar, as well as oligomeric, α-syn enhances membrane permeability.119  It was 
later shown that the presence of WT, E46K, and A53T protein can induce formation 




Van Rooijen et al. showed that the presence of anionic lipids and lipid-
disordered domains affects the ability of α-syn to perturb membranes,132,133 offering 
new insight into the specific conditions promoting membrane disruption.  Subsequent 
study revealed that disruption of vesicles is caused by non-equilibrium processes and 
that despite rapid dye efflux from vesicles membrane morphology is maintained in 
the presence of oligomeric α-syn.134   
Using solid-state NMR and EPR methods it has been determined that α-syn 
pores are comprised of β-sheet structures unique from those found in amyloid 
fibrils.135  In recent work, a low resolution wreath shaped α-syn oligomer was 
identified by x-ray scattering methods and was shown to disrupt liposomes.136                 
Though the specific mechanism of membrane disruption is yet to be 
determined, several recent reports have demonstrated that α-syn also can transform 
membrane surface topology.  This phenomenon was brought to light when it was 
noted that the addition of α-syn to SUVs induced tubular structures as well as 
multilamellar and branched vesicles.39,136  Further work showed that α-syn can 
increase membrane curvature causing smaller vesicles and tubules to form.137  
Accordingly, fluorescence microscopic studies on supported lipid bilayers also 
revealed tubule formation as well as a correlation between increased tubulation and 








3.1  Introduction 
To elucidate the connection between α-syn membrane interactions and PD 
etiology, numerous in vitro biophysical studies to determine membrane-bound α-syn 
conformation have been conducted.  Initial CD studies demonstrated that the protein 
undergoes disordered-to-helical structural changes upon the addition of membrane 
mimics such as SDS micelles and anionic phospholipid vesicles of varying size and 
composition.116  Later, several structural techniques were employed for molecular 
level insights.  α-Syn structures derived from NMR, site-directed spin labeling EPR, 
and fluorescence spectroscopy show large N-terminal α-helical domain formation 
upon membrane binding.139-145  Specifically, SDS-micelle-bound α-syn conformation 
derived from NMR data142 reveal two antiparallel α-helices (residues 3-37 and 45-92) 
separated by a short linker (residues 38-44) while EPR146-148 and single molecule 
fluorescence measurements48,149 using SUVs suggest that one continuous, extended α-
helix is adopted.  In both SDS micelle- and SUV-bound cases, the acidic C-terminal 
region (aa 101 – 140) remains disordered and solvent-exposed.        
                                                 
* Adapted from Pfefferkorn, C. M., Lee, J. C. Tryptophan probes at the α-synuclein and membrane 
interface, J. Phys. Chem. B 114 (2010) 4615 – 4622.  Thanks to Dr. Hank Fales (Laboratory of 
Applied Mass Spectrometry) for technical assistance with ESI-MS, Myoung-Soon Hong (Laboratory 
of Cell Biology), Dr. Mathew Daniels, and Patricia Connelly (Electron Microscopy Core Facility) for 
technical assistance with electron microscopy, Dr. Grzegorz Piszczek (Biophysical Facility) for 
assistance with the dynamic light scattering measurements, and Michel de Messieres for assistance 
with computer modeling. 
 25 
 
Despite numerous work on membrane composition and size effects on α-syn 
membrane binding properties, a consensus on the conditions required to promote α-
syn into one, both, or other variants of the proposed membrane-bound structures 
remains elusive.  It is not clear whether or not these conformers are modulated by 
membrane surface availability (i.e. surface area available for protein binding), 
detergent or phospholipid headgroup composition, or simply solution conditions.  
Indeed, a recent NMR study suggests that there are multiple distinct α-syn membrane 
binding modes that are dependent on α-syn-to-lipid stoichiometry.39  Furthermore, 
given the ability for this protein to undergo large conformational rearrangements, it is 
even more likely that bound structures are not mutually exclusive and can 
interchange.   
Regardless of the specific length and arrangements of α-helical segments, 
based on insights from primary structure as well as structural studies, an 11/3 α-
helical periodicity was proposed for membrane-bound α-syn as is the case of 
apolipoprotein AI.99,100  In an 11/3 α-helix, there are three full turns over 11 residues 
(3.66 residues per turn) as compared to five full turns over 18 residues in an ideal 
helix (3.6 residues per turn).141,145,148  Based on EPR data for SUVs bound α-syn, a 
contiguous 11/3 α-helical region was confirmed for residues 9 – 89.148  A 11/3 helical 
wheel representation of the first 44 N-terminal residues of α-syn is shown in Figure 
3.1.  In this representation, it is clear that acidic residues are water facing while basic 




Figure 3.1  A 11/3 helical wheel representation for residues 1 – 44 of membrane-
bound α-synuclein.  Each residue is denoted by a numbered circle with charged and 
basic residues denoted in red and blue, respectively.  Water, lipid, and interfacial 
regions are indicated for reference.   
 
To develop a detailed understanding of how membranes influence α-syn 
conformation, site-specific probes of protein conformational heterogeneity and 
polypeptide-membrane interactions are necessary.  Fluorescence spectroscopy is 
particularly well suited for this application because of the availability of 
environmentally sensitive fluorophores and the ease of performing experiments near 
physiological temperatures and concentrations even down to a single molecule.  In 
prior work, tryptophan47 and 5-fluorotryptophan150 have been exploited as fluorescent 
amino acids of α-syn conformation and dynamics151,152 in solution.  The emission 
properties of the indole side chain are exquisitely responsive to local environment and 
conformation providing remarkably useful probes of protein-lipid interactions.44,153-157  
















































membrane mimics to investigate membrane-induced conformational changes by 
fluorescence as well as CD spectroscopy.  Tryptophan is substituted at four different 
aromatic residues (F4W, Y39W, F94W, and Y125W) to report on local polypeptide 
environment and conformational heterogeneity in vesicles-bound and SDS-micelles-
bound α-syn.  Furthermore, insights into the role of surface coverage (total number of 
proteins bound and respective surface area occupied) were extracted from saturating 
equilibrium binding curves for all α-synucleins in the presence of vesicles.  
3.2  Materials and Methods 
3.2.1  Materials 
Lipids in chloroform were purchased from Avanti Polar Lipids (Alabaster, 
AL), N-acetyl-tryptophanamide (NATA), and sodium dodecyl sulfate (SDS) were 
purchased from Sigma (St. Louis, MO) and used as received. 
3.2.2  Lipid Vesicle Preparation 
Lipid vesicles were made from a 1:1 molar ratio of 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphate (POPA) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC).  Solutions of 1:1 POPA and POPC dissolved in chloroform were dehydrated 
under a nitrogen stream for 15 minutes followed by vacuum desiccation for 45 
minutes to ensure complete removal of organic solvent.  Dehydrated samples were 
resuspended in 10 mM NaPi, 100 mM NaCl buffer, pH 7.4 to a final concentration of 
5 mg/mL.  Complete dissolution was achieved by bath sonication for 5 minutes.  
Unilamellar vesicles were prepared via ultrasonication in a water bath (45 minutes, 
50% duty cycle, microtip limit, Branson 415 Sonifier).  Vesicle solutions were diluted 
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to a final concentration of 2.5 mg/mL and equilibrated overnight (14 – 24 h) at 30°C.  
Vesicles were prepared freshly for each experiment.  Stock lipid concentrations were 
confirmed using the Bartlett method.158  An average vesicle hydrodynamic radius of 
~40 nm was measured using an 18-angle photometer dynamic light scattering 
instrument with QELS detection (Wyatt EOS).  Vesicle sizes ranged from 20 – 100 
nm as visualized by electron microscopy (JEOL-1200EX). 
3.2.3  Recombinant Protein Expression and Purification 
Wild-type and single Trp-containing α-synucleins were expressed84,159 and 
purified47 as previously reported with minor modifications.  All purification steps are 
performed at 4 °C and a HiPrep 16/10 DEAE FF column (GE Healthcare) is used for 
the first chromatographic step.  The protein was eluted with a linear gradient from 
100 – 300 mM NaCl in 20 mM Tris buffer (pH 7.4 – 8.0).  Protein concentrations 
were determined using a molar extinction coefficient estimated on the basis of amino-
acid content:160 ε280 nm = 5,120 M−1cm−1 (wild-type); ε280 nm = 9,970 M−1cm−1 (Y39W 
and Y125W); ε280 nm = 10,810 M−1cm−1 (F4W and F94W).  The purity of all protein 
samples was assessed by native- and SDS-PAGE on a Pharmacia Phastsystem 
(Amersham Biosciences) visualized by silver-staining methods.  The protein 
molecular weights were confirmed by electrospray ionization mass spectrometry 
(ESI-MS).  All purified proteins were concentrated using Centriprep YM-3 (MWCO 
3kD, Millipore) and stored at −80 °C.  
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3.2.4  Steady-state Spectroscopic Measurements 
Spectroscopic measurements were made as follows: absorption, Cary 300 Bio 
spectrophotometer; CD, Jasco J-715 spectropolarimeter (198 – 260 nm, 1 nm steps, 1 
nm bandwidth, 0.5 s integration time, and 50 nm/min); and luminescence, Fluorolog-
3 spectrofluorimeter (λex = 295 nm, λobs = 300 – 500 nm, 0.20 – 0.25 s integration 
time, 1 nm excitation and emission slit widths).  All measurements were collected at 
25 °C using temperature controlled cuvette holders except for absorbance 
experiments.  Prior to experiments, all protein samples were exchanged into the 
appropriate buffer (10 mM NaPi, 100 mM NaCl, pH 7.4) using gel filtration 
chromatography (PD-10 column, GE Healthcare).  For SDS and lipid titration 
experiments, protein (5 μM) was added to SDS (40 mM) or varying concentrations of 
lipid (0 – 2.5 mM) in appropriate buffer (10 mM NaPi, 100 mM NaCl, pH 7.4), 
respectively.  For inverse titration experiments, varying concentrations of protein (1 – 
20 μM) were added to a fixed concentration of lipid (1 mM) in appropriate buffer (10 
mM NaPi, 100 mM NaCl, pH 7.4).  All protein-SDS and protein-lipid solutions were 
incubated for at least 30 minutes at RT prior to measurement.  Steady-state 
fluorescence spectra were measured before and after laser experiment to verify 
minimal photodamage (<10%). 
3.2.5  Time-resolved Fluorescence Measurements  
Tryptophan fluorescence decay kinetics were measured using the fourth 
harmonic (295 nm) of a regeneratively-amplified femtosecond Ti:sapphire (Clark-
MXR) pumped optical parametric amplifier laser (Light Conversion) as an excitation 
source (60 – 260 μW, 1 kHz) and a picosecond streak camera (Hamamatsu C5680) in 
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photon counting mode for detection.  Tryptophan emission between 325 and 400 nm 
was selected through edge (REF-325) and short-pass (UG-11) filters (CVI Laser).  
Protein samples (3 − 5 μM in 10 mM NaPi, 100 mM NaCl buffer, pH 7.4) were 
deoxygenated on a Schlenk line by 3 sets of 5 repeated evacuation/Ar fill cycles over 
30 minutes.  Buffer solutions were filtered (0.22 µm membrane) to remove any 
particulate matter.  A collection temperature of 25 °C was maintained using a 
temperature controlled cuvette holder.  To ensure good signal to noise, all kinetics 
data were collected such that at least 10,000 counts were achieved in highest channel. 
3.2.6  Circular Dichroism Data Analysis 




][ =Θ , where θ is the measured ellipticity (mdeg), c, the sample 
concentration (mM), l, the path length (cm), and N, the number of amino acids.  




−Θ nm .  
Reference values of [Θ]222 nm =  0 and −36,000 (deg cm2 dmol-1) were used for 0% 
and 100% helicity, respectively.161   
3.2.7  Tryptophan Fluorescence Decay Data Analysis 
Fluorescence decay kinetics were logarithmically compressed (100 points per time 
decade) and normalized (I(t=0) = 1).  Kinetics were fit using a MATLAB (The 
Mathworks, Inc.) algorithm (LSQNONNEG; hereafter referred to as NNLS) that 
minimizes the sum of the squared deviations (χ2) between the observed and calculated 
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values of I(t), subject to a nonnegativity constraint on the probability distribution of 
rate constants, P(k).  NNLS fitting produces the narrowest P(k) distributions.47,162 
3.2.8  Protein-membrane Equilibrium 
Binding equilibrium data were modeled according to the simple law of mass 
action for identical and independent binding sites.163,164  Estimation of apparent 
association constants were extracted for the following two-state equilibrium:  





K =  (3.1) 
where fP  is the free α-syn concentration, fB  is the free binding sites, and bPB  is the 
bound α-syn concentration (occupied binding sites).  The total binding sites (Bt) is 
defined as LBmax , where maxB  is the maximum binding sites per lipid molecule, and 
L is the total lipid concentration.  Substituting bft PBPP +=  and 
LBPBBB bft max=+=  into the expression for 
app
aK  and using the definition of Bt, 
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, Eq. 3 can be solved for our 
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(3.4) 
Fitting was performed using IGOR Pro 6.01 (Wavemetrics). 
3.2.9  Protein Packing on Lipid Vesicles 
The number of lipid molecules per vesicle was estimated by dividing total 
vesicle surface area by the area per lipid molecule parallel to the bilayer surface.  A 
total of 56,795 lipid molecules per vesicle was calculated using 40 nm for outer 
vesicle radius, 0.643 nm2 for the lipid area (estimated using DPPC), and 3.86 nm for 
the bilayer thickness.165,166  This number is consistent with that predicted from the 
molecular weight of a hydrated vesicle.167  Estimation of the maximum number of α-
synucleins binding to vesicles was calculated by modeling the proteins as rigid bodies 
of dimensions consistent with α-syn in continuous extended-148 (14.97 nm) and bent-
helical142,143 (approximate segment lengths: helix 1 = 5.5 nm, linker = 1.4 nm, helix 2 
= 6.8 nm) conformations.  Using a value of 0.75 nm for the protein-helix diameter, 
we estimate an area of 11.3 nm2 and 10.3 nm2 is required for α-syn to bind in bent-
helical and extended-helical conformations, respectively.  Maximum α-synuclein 
packing number on a vesicle using Bmax (maximum number of protein binding sites 
per lipid molecule) were calculated considering that only the lipid molecules on the 
outer leaflet of the vesicle (~31,300) are available for protein binding.  Percent 




3.2.10  Computer Simulation  
Computer simulations used to approximate α-syn vesicle binding saturation 
numbers considered only geometrical packing constraints.  Proteins were modeled as 
rigid bodies of dimensions consistent with those for α-syn in continuous extended- 
(14.97 nm) and bent-helical (approximate segment lengths: 5.5 nm helix 1, 1.4 nm 
linker, 6.8 nm helix 2) conformations.  Saturation number was determined when 
10,000 successive attempts to randomly place simulated proteins on a sphere of fixed 
radius were unsuccessful.   
3.3  Results and Discussion 
3.3.1  Membrane-mediated α-Helical Structure Formation 
To monitor site-specific interactions of α-syn membrane binding, four single 
tryptophan-containing proteins (F4W, Y39W, F94W, and Y125W) were produced.  
CD spectroscopy was employed to assess the effects of the Trp mutations and to 
characterize vesicle-induced secondary structural changes for all α-synucleins.  In pH 
7.4 buffer solutions (10 mM NaPi, 100 mM NaCl, 25 °C), CD spectra for wild-type 
and Trp variants (3 – 5 μM) exhibit a dominant minimum near 200 nm that is 
consistent with random coil configurations.  With increasing amounts of anionic 
phospholipid vesicles (equal molar POPA, anionic –1 per headgroup, and POPC, 
zwitterionic) the CD spectra show prototypical features (negative maxima at 208 and 





Figure 3.2  Phospholipid vesicles induced secondary structure in α-synuclein.  
Representative far UV CD spectra of Y39W α-syn (5 μM) as a function of increased 
lipid vesicles (0 – 2 mM 1:1 POPA:POPC in 10 mM NaPi, 100 mM NaCl buffer at 
pH 7.4, 25 °C).  
 
The spectra for the Trp mutants were indistinguishable from the wild-type 
protein, indicating that this naturally occurring fluorophore does not change the 
secondary structure of vesicle-bound protein under these solution conditions.  An 
isodichroic point (204 nm) suggests that binding is consistent with an unstructured to 
α-helical conformation transition with a maximum total α-helical content of ~67% 
(mean residue ellipticity at 222nm, [Θ]222 nm, = −23,130 deg cm2 dmol-1), consistent 
with previously reported values.116  Similarly, all α-syn variants exhibit an α-helical 
content of ~67% in the presence of SDS micelles, demonstrating not only that 
substitution of Trp residues does not perturb micelle-bound structure, but also that α-
helical content is not a distinguishing feature between vesicle- and SDS micelles-




Figure 3.3  Phospholipid vesicle and sodium dodecyl sulfate (SDS) micelles induced 
secondary structure in α-synuclein.  Representative CD spectra of F4W α-syn (5 μM 
α-syn in 10 mM NaPi, 100 mM NaCl buffer at pH 7.4, 25°C) (black) and with the 
addition of SDS micelles (40 mM) (blue) and lipid vesicles (2 mM 1:1 POPA:POPC) 
(red). 
 
As α-syn has substantially reduced affinity for zwitterionic vesicles,168 100% 
POPC vesicles (at highest lipid concentration ~2 mg/mL) were employed to assess 
macromolecular crowding effects.  No apparent conformational transitions were 
observed for wild-type and Trp mutants verifying the involvement of electrostatic 
interactions in membrane binding affinity (Figure 3.4).  
 
Figure 3.4  Effect of zwitterionic vesicles on α-synuclein membrane binding.  
Representative far UV CD and steady-state fluorescence emission spectra of F4W α-
syn (5 μM) as a function of increased lipid vesicles (0 – 2 mM POPC in 10mM NaPi, 
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Membrane binding curves were generated for all proteins using mean residue 
ellipticity (Figure 3.5).  All isotherms are nearly identical and reversible, with similar 
midpoint transitions (lipid-to-protein molar ratio of 120 − 160) approaching saturation 
at a lipid-to-protein molar ratio of ~380.  Interestingly, while α-synuclein membrane 
binding curves generated from calorimetric113 and single molecule fluorescence168 
techniques are not well described by membrane-partition models, adequate fits to CD 
data using a law of mass action for identical independent binding sites were 
achieved.163,164  An apparent association constant ( appaK  ~ 1 × 10
7 M-1) and a total 
number of binding sites per lipid molecule (Bmax ~ 0.004) were extracted for all α-
synucleins.  To ensure that appaK  values derived from CD data were independent of 
bound polypeptide concentration in the low lipid-to-protein regimes, inverse 
fluorescence titrations also were performed in which protein concentration was varied 






Figure 3.5  Comparison of vesicle binding properties of wild-type and fluorescent 
single Trp α-synucleins. (Top) Schematic representation of α-synuclein primary 
sequence with the tryptophan mutations (F4W, Y39W, F94W, and Y125W) 
highlighted.  (Bottom) Normalized change in mean residue ellipticity (Δ[Θ]) as a 
function of lipid-to-protein (bottom axis) as well as an estimated protein-to-vesicle 
(average diameter ~80 nm) ratio (top axis) (0 – 2.5 mM 1:1 POPA:POPC in 10 mM 
NaPi, 100 mM NaCl buffer, pH 7.4, 25°C) for wild-type(•), W4(•), W39(•), W94(•), 
and W125 (•) variants.  A representative fit is shown as a line. 
 
 
Figure 3.6  Inverse fluorescence lipid titration of F4W α-synuclein.  Representative 
comparison of F4W α-syn membrane binding curves derived from CD (Δ[Θ]222 nm) 
and from inverse fluorescence titrations Δ I/Io, where I is the integrated fluorescence 
intensity and Io is the initial fluorescence intensity of protein alone). 
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Because α-syn membrane binding likely is affected by electrostatic repulsion 
of the acidic C-terminal tail, our appaK  values are unexpectedly similar to several full 
length apolipoproteins (apoPs) (apoA-I and apoE4 (egg PC), appaK  = 8.3 × 10
5 and 8.3 
× 106 M-1, respectively).163,169  While appaK  values for α-syn suggest comparable 
affinity as the apoPs, we would anticipate an isolated N-terminal amphiphilic α-syn 
polypeptide would bind to membranes even more tightly.  Furthermore, the full length α-
syn membrane affinity would be expected to increase in solution conditions favoring 
charge neutralization (acidic pH) and the binding of biomolecules or metal ions such 
as polyamines170 and calcium ions103 to the C-terminus.   
3.3.2  Estimation of α-Synuclein Vesicle Surface Coverage 
Using CD binding curves the possible role of membrane surface coverage in 
modulating α-syn conformation was assessed.  Assuming that only outer leaflet lipids 
bind proteins and using Bmax obtained from fits, we find that the vesicle surface 
contains ~120 protein binding sites with ~250 lipids per binding site.  If all binding 
sites are occupied, only ~7% of the total vesicle surface would be covered by proteins 
(see Materials and Methods).  Simple geometrical estimates of the total possible 
number of α-syn proteins bound to vesicles in both bent- and extended-helical 
conformations are higher than our experimentally derived value (~1000 and ~650 
respectively).  These disparities likely are attributable to repulsive electrostatic 
protein-protein and even phospholipid-protein interactions with the acidic C-
terminus.  Our data suggest that α-syn proteins are not closely packed on the 
membrane surface at binding saturation; this result is consistent with electron spin 
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resonance data (36 – 100 lipids per protein; DMPG).171  Interestingly, the surface 
coverage determined for α-syn is low compared to other peripheral membrane 
proteins such as apocytochrome c (2 lipids per protein; DMPG)171,172 and myelin 
basic protein (18 lipids per protein; DMPG).171,173   
Notably, α-syn fibril formation in the presence of low lipids (lipid-to-protein 
molar ratio ~4) is ~3.5 times faster than protein alone.119  For this case, we estimate a 
staggering ~14,000 proteins-per-vesicle; a value significantly higher than the 
maximum binding sites per vesicle.  While our data suggest that α-syn proteins are 
not closely packed at saturation, it is plausible that changing the lipid-to-protein ratio 
could result in conformational rearrangement at the vesicle surface, a phenomena 
observed in apocytochrome c.172  Because intracellular synaptic vesicles contain 
heterogeneous distributions of phospholipid headgroups and membrane-associated 
proteins, the biological relevance of the conformational rearrangement of α-syn due 
to protein packing remains to be elucidated.    
3.3.3  Site-specific Tryptophan Probes of α-Synuclein Membrane Interactions 
Site-specific interactions of α-syn with phospholipid vesicles were monitored 
by measuring steady-state and time-resolved Trp fluorescence as a function of 
POPA:POPC vesicle concentration (0 – 2.5 mM in 10 mM NaPi, 100 mM NaCl 
buffer at pH 7.4).  In solution, all four Trp residues exhibit identical fluorescence 
maxima at 348 nm consistent with water-exposed side chains and similar local protein 
conformations.  The model complex, N-acetyl-tryptophanamide also has a maximum 
at 348 nm under similar solution conditions.  However, upon addition of phospholipid 
vesicles, Trp photophysical properties become site-dependent with differences in the 
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emission maxima (F4W > F94W ~ Y39W >> Y125W, Figure 3.7 and Figure 3.8) and 
quantum yields (F4W ~ F94W > Y39W >> Y125W, Figure 3.7).  In particular, F4W 
exhibits a pronounced spectral blue shift (Δλmax = 23 nm) reminiscent of integral (E. 
Coli outer membrane protein A (OmpA): Δλmax = 25–28 nm, DMPC)50,51 rather than 
surface-bound membrane proteins (mimics of the class A1 helices in exchangeable 
apoPs: Δλmax = 14 nm, POPC).98  In addition, the three fold increase in W4 quantum 
yield is consistent with this side chain partitioning into the bilayer.  While this residue 
was initially predicted to be membrane exposed using SDS micelles studies,142 it was 




Figure 3.7  Site-specific tryptophan fluorescence of α-synucleins.  Steady-state 
emission spectra of F4W, Y39W, F94W, and Y125W (top to bottom) α-syn mutants 
in the presence of lipid vesicles (0-2.5 mM 1:1 POPA:POPC in 10mM NaPi, 100 mM 
NaCl buffer, pH 7.4, 25 °C).  For all steady-state spectra, lipid vesicle backgrounds 





Figure 3.8  Mean wavelength of Trp α-synucleins as a function of lipid vesicles.  
Mean wavelength of spectral distribution, λ , for F4W, Y39W, F94W, and Y125W 
α-synucleins (5 μM) as a function of increased lipid vesicles (1:1 POPA:POPC in 








λλ , and λ and 
I  are wavelength and intensity, respectively.     
 
In contrast, W39, which is located in the loop region of the micelle-bound 
NMR structure142 and water-exposed in the SUV-bound conformation,148 exhibits a 
modest spectral blue shift (λmax ~339 nm, Δλmax ~10 nm) and QY increase (1.2 fold) 
in the presence of vesicles.  These reduced Y39W fluorescence changes compared to 
that of F4W point to greater water exposure, consistent with proposed micelle and 
liposome bound conformations.  Located in the C-terminal end of the NAC region, 
F94W exhibits a similar emission spectral shift as Y39W (λmax ~ 338 nm Δλmax ~ 9 
nm), but a significant QY increase (comparable to W4) upon vesicle binding 
suggesting that this indole is lipid-exposed or in a conformation that alleviates 
nonradiative pathways (e.g. restriction of mobility and electron transfer).  The 
pronounced spectral response of F94W to membranes is particularly interesting and 





















and, while micelle facing, is unstructured when bound to SDS.142  It is important to 
note that Trp fluorescence quantum yields are modulated by local charges as well as 
fluorophore mobility.52  If the indole ring is in close proximity to a positive (negative) 
charge then its quantum yield could increase (decrease).  It is plausible as the protein 
binds to the membrane surface, W94 may become closer to K96, the closest 
intramolecular positive charge.  Alternatively, W94 may reside near the 
trimethylammonium cation of the POPC headgroup.  Not surprisingly, Y125W 
fluorescence remains unchanged in the presence of phospholipid vesicles confirming 
that the C-terminal tail remains in solution.  Although Y125W is unresponsive, it 
provides a control to ensure that our spectroscopic changes are solely due to protein-
membrane interactions and not the mere presence of the membranes themselves.  To 
further verify that the emission features were not a result of macromolecular 
crowding, the spectra of all Trp variants in the presence of zwitterionic POPC 
vesicles were obtained.  No changes were observed even at the highest vesicle 
concentrations (Figure 3.9).  
 
Figure 3.9  Effect of zwitterionic vesicles on α-synuclein membrane binding.  
Representative steady-state fluorescence emission spectra of F4W α-syn (5 μM) as a 
function of increased lipid vesicles (0 – 2 mM POPC in 10mM NaPi, 100 mM NaCl 
buffer at pH 7.4, 25 °C). 
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  Because secondary structural characterization does not provide a 
distinguishing marker of micelle- vs. vesicle-bound proteins (Figure 3.3), Trp 
fluorescence data also were collected for SDS micelles-bound α-synuclein (Figure 
3.10).  In all positions except W125, Trp data reveal significant differences for 
vesicle- and SDS micelles-bound conformations.  The F4W spectrum in the presence 
of SDS micelles (40 mM, critical micelle concentration = 1.33 mM174 (100 mM 
NaCl, 25°C)) exhibits a QY decrease (20% decrease compared to in solution) and the 
spectral shift is greatly reduced (Δλmax = 23 (vesicles) → 15 (micelle) nm).  The 
reduced QY suggests considerable differences in the local polypeptide conformation 
near the vicinity of residue 4.  The reduced spectral shift also supports different 
protein-lipid interactions (head group vs. hydrocarbon chain) as well as variations in 
micellar vs. bilayer microenvironment hydration.  Interestingly, in the presence of 
SDS micelles, Y39W also exhibits a decrease in QY which may be due to its 
proximity to a Trp quencher, such as His50, the most likely side chain in the amino 
acid sequence to participate in excited-state deactivation processes (there is no native 
Cys and only one His).154  Examination of the SDS structure (PDB 1XQ8)142 reveals 
that the nearest negative charges (E35) is over 15 Å away and the nearest positive 
charge (K45) is much closer (8 Å) to Y39.  Because these side chains are relatively 
distant, likely it is the proximity of W39 to the sulfonate groups that is responsible for 
the reduced quantum yield (vide supra).  In contrast, W94 appears to be the most 
sensitive probe for micelle interaction with both a spectral shift and an increase in 
quantum yield, qualitatively similar to that of the bilayer.  Not surprisingly, the 
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Y125W spectrum remains unchanged, indicating that both micelle- and vesicle-bound 
conformers have C terminal regions that remain solvent exposed. 
 
Figure 3.10  Comparison of tryptophan fluorescence for micelles- and liposome-
bound α-synuclein.  Steady-state emission spectra for F4W, Y39W, and F94W (top to 
bottom) in buffer (10mM NaPi, 100 mM NaCl, pH 7.4) (light blue), bound to SDS 
micelles (40 mM) (red), and at saturating SUV concentrations (2.0 – 2.5 mM 1:1 
POPA:POPC) (blue).        
 
  Our steady-state fluorescence data clearly demonstrate site-specific 
differences for the SDS micelle and liposome-bound α-syn conformers.  While the 






conformations, the quantum yields reveal distinct behavior, particularly highlighting 
the local polypeptide environmental changes of W4.  Notably, W4 and W94 were not 
characterized in the continuous α-helical (residues 9 – 89) membrane-associated 
structure reported by Langen and coworkers.148  If we use the periodicity of 3.66 aa 
per turn from Langen148 and previous NMR studies on micelles,145 then W4 and W94 
are predicted to be lipid- and solvent-exposed, respectively.  Since our data 
demonstrate that both W4 and W94 partition into the bilayer, we suggest that this α-
helical periodicity (3.66 aa per turn) spans from residues 4 to 89 and is not extended 
to position 94.  However, the strong spectral response we observe for W94 does 
suggests that this residue interacts directly with the micelle.  Taken together, our 
vesicle and micelle data support that there are more protein-membrane interaction 
sites beyond helical regions.   
3.3.4  Conformational Heterogeneity of Phospholipid Vesicles-bound α-
Synuclein Monitored by Tryptophan Kinetics  
To characterize membrane-bound protein conformational heterogeneity we 
measured tryptophan decay kinetics for F4W, Y39W, F94W, and Y125W α-
synucleins (Figure 3.11).  For all variants and solution conditions, decay kinetics are 
not well described by single exponential functions as it is typically observed for Trp-
containing proteins attributable to side chain local environments and 
conformations.44,153,154,157  Accordingly, we used a nonnegative linear least squares 
method to analyze our data which produces the narrowest probability distribution of 
lifetimes (P(τ)) required to fit the decay kinetics and distinguish protein 
subpopulations (see Figure 3.12 for residuals).47  Our time-resolved data are 
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consistent with steady-state observations (F4W and F94W: increases in average 
fluorescence lifetime (<τ>); Y39W: modest changes in <τ>; Y125W: no changes, 
Figure 3.11).  Notably, the P(τ) extracted from our fits provided insights in the 
evolution of subpopulations in the protein ensemble and revealed local 
conformational heterogeneity that was not apparent through steady-state analyses.      
 
Figure 3.11  Time-resolved Trp fluorescence decay kinetics of F4W, Y39W, F94W, 
and Y125W (top to bottom) α-syn mutants in the presence of lipid vesicles (1:1 
POPA:POPC (midpoint and saturated concentrations: 0.5 mM and 2.0 mM 




Figure 3.12  Non negative least squares fitting of Trp decay kinetics.  
Logarithmically compressed (100 points per time decade) and normalized (I(t=0)=1) 
fluorescence decays (blue) with corresponding NNLS fits (red) and fitting residuals 
(black) for W4 (top) and W94 (bottom) α-synucleins in buffer (10 mM NaPi, 100 mM 
NaCl, pH 7.4, 25°C) (left) and at midpoint (middle) and saturated (right) 
concentrations of 1:1 POPA:POPC (0.5 mM and 2.0 mM respectively). 
 
In solution (10 mM NaPi, 100 mM NaCl, pH 7.4), two (<τ1> = 3.0 ns, P(τ1) = 
57%; <τ2> = 1.0 ns, P(τ2) = 43%) and three (<τ1> = 4.2 ns, P(τ1) = 24%; <τ2> = 2.1 
ns, P(τ2) = 59%; <τ3> = 0.5 ns, P(τ3) = 17%) distinct populations were observed for 
W4 and W94, respectively (Figure 3.13).  For both W4 and W94, vesicle-bound 
decays generally are characterized by increases in average lifetimes as a function of 
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added vesicles; however, the evolution of the individual lifetimes is distinct for W4 
and W94.    Upon vesicle addition, W4 exhibits characteristic <τ> increases (<τ1>: 
3.0 ns → 5.7 ns; <τ2>: 1.0 ns → 1.7 ns) with only modest changes in relative 
amplitudes (P(τ1): 57% → 41%; P(τ2): 43% → 59%).  These average lifetime 
increases are consistent with those that have been observed for folding of single-Trp 
containing OmpA into DMPC SUVs (τ1: 4.5 − 5.5 → 5.3 − 6.3 ns; τ2 = 1.5 − 1.8 → 
2.1 − 2.7 ns (urea → DMPC)).50  The small relative amplitude changes in P(τ) 
coupled to increases in both <τ1> and <τ2> suggest that all F4W subpopulations are 
sensitive to the presence of the bilayer.  Similar to W4, two W94 subpopulations 
change with vesicle addition; however, F94W kinetics reflect an increased 
conformational heterogeneity not observed in F4W.  While both τ1 and τ2 increase in 
average lifetime (<τ1>: 4.2 ns → 7.7 ns; <τ2>: 2.1 ns → 2.7 ns) indicative of a 
membrane-bound conformations, the relative amplitude of τ2 is appreciably decreased 
in favor of τ1 (P(τ1): 24% → 40%; P(τ2) 59% → 41%) suggesting a conformational 
transition that is dependent on lipid-to-protein ratio.  The presence of a third 
component τ3 that exhibits no significant changes in <τ> or P(τ) even at saturating 
lipid concentrations in addition to the change in P(τ3) is suggestive of a unbound 
subpopulation.  However, because τ3 represents < 25% of the total distribution and τ2 
exhibits only a modest lipid induced lifetime increase, the exact nature of this 
heterogeneity is not clear.  The presence of an unbound subpopulation would not be 
surprising because of the electrostatic repulsion due to the acidic C-terminus in this 
region.  Alternatively, because the Trp excited state captures nanosecond snapshots of 
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the protein ensemble, heterogeneity observed in W94 could reflect side chain 
dynamics.  
 
Figure 3.13  Analysis of time-resolved Trp fluorescence decay kinetics for α-
synucleins.  Representative probability distribution of fluorescence lifetimes (P(τ)) 
extracted from NNLS fits for F4W (top) and F94W (bottom) α-synucleins in buffer 
(10 mM NaPi, 100 mM NaCl, pH 7.4, 25 °C) and at midpoint and saturated 
concentrations of 1:1 POPA:POPC (0.5 mM and 2.0 mM respectively) (left), 
variations in individual average lifetimes (<τi>) (middle) and the development of 
individual lifetime populations (P(τi)) (right) as a function of added lipids. 
  
While assignment of distinct populations is challenging due to the smaller 
dynamic range for changes in Y39W, inspection of the kinetics do reflect a 
conformational heterogeneity similar to that of F94W (data not shown).  Although the 
W39 decays accelerate only modestly, there is a consistent development of shorter 
lifetime components from buffer to vesicle-containing solutions which is atypical for 
lipid-associated changes.  It appears that upon membrane binding, there may be 
quenchers in closer proximity to W39 as a result of local conformational changes 
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(vide supra).  Finally, consistent with steady-state results, Y125W decay kinetics are 
not affected to the presence of vesicles even at saturating lipid conditions.   
Time-resolved analyses demonstrate that all sites examined (except W125) 
have interactions with the membrane.  Particularly, our data suggest that W4 is a high 
affinity membrane binding site with increases in average lifetimes for all components; 
it appears that W4 kinetics are sensitive to the presence of vesicles even at low lipid 
concentrations (100 μM, [lipid]midpoint = 500 μM).  Though exhibiting only modest 
changes, residue W39 does exhibit conformational heterogeneity with increases in 
average lifetime with vesicle addition.  Our Y39W data agree with both micelle- and 
liposome-bound structures in that this residue is likely both solvent-exposed and 
flexible at the interface of the lipid headgroups and the surrounding solvent.  While 
F94W steady-state results show a spectral response comparable to that of F4W, 
F94W kinetics data also reveal conformational heterogeneity for this position with 
vesicle addition.  The local conformational change between the solvent-to-lipid or 
different lipid-bound states is evidenced in the lipid concentration dependent decrease 
in P(τ2) in favor of P(τ1).  F94W data could indicate that protein-membrane 
stoichiometry is crucial in modulating membrane interactions in this region of the 
protein.  Moreover, W4 could act as an anchor with all populations sensitive to the 
membrane at all lipid concentrations, while W94 has both lipid and solvent exposed 
conformers that are dependent on lipid-to-protein ratio.  It is noteworthy that the 
hydrophobic NAC region has been proposed to be secluded from intermolecular 
contacts by the intra-molecular N- and C-terminal interactions.175  Similarly, it is 
feasible for membrane stimulated aggregation to arise because as the local protein 
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concentration increases at the surface, polypeptide conformational rearrangement 
ensues leading to exposure of potential protein-protein interaction sites promoting 
amyloid formation.    
3.4  Summary 
We have demonstrated that Trp fluorescence is a sensitive, site-specific probe 
of α-syn interactions with both vesicles (QY: F4W ~ F94W > Y39W >> Y125W; 
<λ>: F4W > F94W ~ Y39W >> Y125W) and micelles (quantum yield: F94W > F4W 
> Y125W > Y39W; <λ>: F4W > F94W ~ Y39W >> Y125W).  Vesicle-binding 
curves generated from steady-state CD and fluorescence data can be described by a 
two-state equilibrium partition model with appaK  ~ 1 × 10
7 M-1.  We estimate that α-
syn binds to POPA:POPC vesicles with a relatively low surface coverage ~7% (~120 
proteins for a 80 nm diameter vesicle) at saturation.  Furthermore, measurements of 
fluorescence decay kinetics reveal the presence of protein conformational 
heterogeneity in the bilayer, suggesting that the both W4 and W94 exhibit high 
membrane affinity.  Notably, both of these sites have not been characterized 
previously in the vesicle-bound α-syn structure.148  With this approach, the crucial 
protein-to-membrane conditions and key sites of interaction that promote membrane-




Chapter 4: Molecular Insights of N-terminal α-Synuclein at 
the Membrane Interface* 
 
4.1  Introduction 
Though substantial biophysical research efforts have provided insights into 
the interaction of α-syn with model membranes, a molecular understanding of the role 
of specific key residues in mediating membrane binding is still unclear.  However, 
recent fluorescence,102 NMR,39 and isothermal titration calorimetry176 studies point 
toward the importance of N-terminal residues.  The biological relevance of the N-
terminus of α-syn in membrane binding is underscored by a recent report using 
Saccharomyces cerevisiae as a cellular model system in which α-syn induced cell 
toxicity is mediated by the presence of N-terminal residues; deletion of even one 
amino acid (D2) in this region can significantly enhance cell viability.177
 Biophysical evidence from site-specific fluorescence and NMR data indeed 
suggest that vesicles-bound α-syn conformation is dependent on α-syn-to-lipid 
stoichiometry and that high affinity N-terminal residues could serve as a protein-
membrane anchor under certain low lipid solution conditions.39,102  Based on the 
disappearance of solution NMR signals, two distinct binding modes were 
characterized, SL1 and SL2, corresponding to the association of the first 25 and 97 
residues, respectively.  As the lipid-to-protein ratio is increased, decreases in the ratio 
                                                 
* Thanks to Alex Maltzev (Laboratory of Chemical Physics, NIDDK) for collecting NMR data, Ad 
Bax (Laboratory of Chemical Physics, NIDDK) for the use of the NMR spectrometer, and Grzegorz 




of the SL1 to SL2 binding mode were observed.  Evidence for the presence of 
multiple-membrane bound conformations also can be found in time-resolved 
tryptophan fluorescence data showing increased heterogeneity near the C-terminal 
site, W94, compared to that of the N-terminal probe, W4.102  The idea that different 
regions of α-syn can associate with the membrane under different solution conditions 
is further corroborated by a recent study of the role of the N-terminus in α-syn 
membrane binding.176  In this study, it was found that different isolated regions of the 
α-syn sequence bind to membranes to various degrees and that secondary structural 
formation for each of these regions is dependent on lipid composition as well as other 
factors such as temperature.176  This study further suggests that the N-terminus, 
specifically the first 25 residues, is involved in the membrane induced polypeptide 
folding.176       
In this chapter, a range of experimental tools are used to identify the role of N-
terminal residues in membrane binding.  Specifically, the spectroscopic properties of 
a series of synthetic W4 containing peptides: residues 1 – 4 (P4), 1 – 6 (P6), 1 – 10 
(P10), and 1 – 15 (P15) (Figure 4.1) are measured to determine a minimal N-terminal 
amino acid sequence to preserve phospholipid vesicle binding.  Furthermore, we 
examine how membrane binding is modulated by the presence of the consensus 
amphipathic repeat (residues 11 – 15; P15), the addition of lysine residues, K6 (P6) 
vs. K10 (P10), and the shortest sequence (P4) required for our fluorescent studies.  
Trp4 is used because it has been demonstrated to be a particularly sensitive reporter 
of polypeptide environments and conformational changes in the presence of 
biomolecules such as lipids102 or copper.159  Moreover, W4 is a minimalist probe that 
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does not significantly affect membrane binding properties in the full length protein102 
or in the P15 peptide (vide infra) as evidenced by CD spectroscopy (CD) and 1-
dimensional (1D) 1H NMR, respectively.  CD and 1-D 1H NMR also were measured 
to assess the role of other (non-fluorescent) residues in secondary structural formation 
and membrane interactions, respectively.  To determine the penetration depth of the 
W4 into the bilayer as a function of polypeptide length, phospholipids in which 
specific sites in the phospholipid acyl-chain region are labeled with the heavy-atom 
fluorescence quencher bromine, were employed.  
 
Figure 4.1  Schematic representation of full-length α-synuclein with the seven 
amphiphatic amino acid imperfect repeat regions (KXKEGV) highlighted (blue).  The 
sequence for N-terminal peptides is also given with the single tryptophan site (W4; 
bold and underlined) and lysine residues (italics) highlighted. 
 
4.2  Materials and Methods 
4.2.1  Materials 
Phospholipids (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (POPA), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-(6,7-
dibromo)stearoyl-sn-glycero-3-phosphocholine (Br6-7PC), 1-palmitoyl-2-(9,10-
dibromo)stearoyl-sn-glycero-3-phosphocholine (Br9-10PC) and 1-palmitoyl-2-(11,12-
dibromo)stearoyl-sn-glycero-3-phosphocholine (Br11-12PC)) were purchased from 









(NATA) was obtained from Sigma-Aldrich (St. Louis, MO).  Synthetic C-terminally 
amidated peptides (>95% purity) were purchased from Anaspec, Inc. (San Jose, CA) 
and D2O from Cambridge Isotopes Laboratory (Andover, MA).   
4.2.2  Recombinant Protein Expression and Purification 
Wild-type (WT) and F4W α-syn were expressed and purified as previously 
reported.102  Protein concentration was determined using a molar extinction 
coefficient estimated on the basis of amino-acid content: ε280 nm = 5,120 M−1cm−1 and 
10,810 M−1cm−1 for WT and F4W, respectively.  The purity of protein samples was 
assessed by SDS-PAGE on a Pharmacia Phastsystem (Amersham Biosciences) and 
visualized by silver-staining methods.  The protein molecular weights were confirmed 
by electrospray ionization mass spectrometry (Biochemistry Core Facility, NHLBI).  
All purified proteins were concentrated using a YM-3 filter (MWCO 3kD, Millipore) 
and stored at −80 °C.  
4.2.3  Phospholipid Vesicle Preparation  
Phospholipid vesicles were made from a 1:1 molar ratio of POPA and POPC.  
For Trp penetration depth experiments, brominated-PC lipids (BrPC: Br6-7PC, Br9-
10PC, and Br11-12PC) were added to a final molar concentration of 30% while 
maintaining an overall 1:1 molar ratio of PA and PC.  Chloroform solutions of 1:1 
POPA and POPC or 1:1 POPA and POPC/BrPC were dried under a nitrogen stream 
for 20 min followed by vacuum desiccation for 45 min to ensure complete removal of 
organic solvent.  Dried samples were then resuspended in 10 mM NaPi, 100 mM 
NaCl buffer, pH 7.4 to a final concentration of 5 mg/mL by bath sonication for 5 – 10 
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min.  Vesicles were prepared via ultrasonication in a water bath (45 minutes, 50% 
duty cycle, microtip limit, Branson 450 Sonifier).  Vesicle solutions were diluted to a 
final concentration of 2.5 mg/mL, equilibrated overnight (14 – 24 h) at 37 °C, and 
prepared freshly for each experiment.  Average vesicle hydrodynamic radius was 
determined to be 45 – 55 nm by dynamic light scattering (Wyatt DynaPro NanoStar; 
fifty 5-s acquisitions, 25 °C).   
4.2.4  Steady-state Spectroscopic Measurements 
Spectroscopic measurements were made as follows: absorption, Cary 300 Bio 
spectrophotometer; CD, Jasco J-715 spectropolarimeter (205 – 260, 1 nm steps, 1 nm 
bandwidth, 0.5 s integration time, and 50 nm/min, 5 mm cuvette pathlength), and 
luminescence, Fluorolog-3 spectrofluorimeter (λex = 295 nm, λobs = 300 – 500 nm, 
0.25 s integration time, 1 and 2 nm excitation and emission slit widths, respectively).  
All measurements were collected at 25 °C using temperature controlled cuvette 
holders except for absorbance experiments.  For all spectra measured in the presence 
of vesicles, background scans were collected and subtracted.  Though CD spectra for 
most samples was collected between 200 and 260 nm, due to the high scattering 
associated with high vesicle concentrations, CD data between 205 and 260 nm is 
presented herein.  Prior to all experiments, F4W α-syn was exchanged into 10 mM 
NaPi, 100 mM NaCl, pH 7.4 buffer using a PD-10 column (GE Healthcare).   
All α-syn N-terminal peptides (P4, P6, P10, P15 and the 1 – 15 wild type 
sequence) had the C-terminus amidated and were used as received.  Stock peptide 
solutions were prepared in deionized H2O prior to dilution to the desired final 
concentration.  A molar extinction coefficient ε280 nm = 5,500 M−1cm−1 was used to 
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estimate peptide concentration for P4, P6, P10, and P15.  For the 1 – 15 wild-type 
peptide, protein concentration was determined by measuring the mass of lyophilized 
stock prior to dilution.  All protein and peptide solutions containing vesicles were 
incubated for at least 30 min at RT prior to measurement.  For Trp quenching 
experiments, a phospholipid-to-protein/peptide molar ratio of 300 (1.5 mM 
phospholipid) was used.  Under these conditions, all peptides are at binding saturation 
with the exception of P6 and P4. 
4.2.5  Circular Dichroism Spectroscopy         




][ =Θ  wh ere θ  is the measured ellipticity (mdeg), c is the sample 
concentration (mM), l is the path length (cm), and N is the number of amino acids.  












1(000,40][ +−−=Θ  and Tcoil 45640][ −=Θ , and T is the temperature 
in °C.176 
4.2.6  1H Nuclear Magnetic Resonance Spectroscopy 
1D 1H NMR experiments were performed on 10 μM α-syn peptide samples 
(P4, P6, P10 and P15) in the absence (10 mM NaPi, 100 mM NaCl, pH 7.4; 2.6% 
D2O) and presence of 1:1 POPA:POPC phospholipid vesicles (lipid-to-protein molar 
ratio of 300, 3 mM POPA:POPC).  Measurements were made using a Bruker DMX-
600 spectrometer operating at 600 MHz hydrogen frequency and equipped with a RT 
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probe.  For each experiment 32,000 scans were acquired over the course of 15 h with 
acquisition time of 70 ms and the spectral width of 12 ppm.  Sample temperature was 
set to 25 ºC. 
4.2.7  Time-resolved Fluorescence Anisotropy 
Tryptophan fluorescence anisotropy decay kinetics were measured using the 
fourth harmonic (292 nm) of a regeneratively-amplified femtosecond Ti:sapphire 
(Clark-MXR) pumped optical parametric amplifier laser (Light Conversion) as an 
excitation source (80 – 120 μW, 1 kHz) and a picosecond streak camera (Hamamatsu 
C5680) in photon counting mode for detection.  Tryptophan emission between 325 
and 400 nm was selected through edge (REF-325) and short-pass (UG-11) filters 
(CVI Laser).  Polarized Trp excited state decays (I⊥(t) and I׀׀(t) were measured 
simultaneously with an optical fiber array and corrected for differences in collection 
efficiency of vertically and horizontally polarized light using the Trp model complex, 
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, of NATA.  Prior to measurement, all protein and peptide samples (5 
μM in 10 mM NaPi, 100 mM NaCl buffer, pH 7.4) and samples containing vesicles 
(lipid-to-protein molar ratio of 300, 1.5 mM POPA:POPC) were deoxygenated on a 
Schlenk line by 3 sets of 5 repeated evacuation/Ar fill cycles over 30 min.  All buffer 
solutions were filtered (0.22 μm membrane) to remove any particulate matter.  A 
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collection temperature of 25 °C was maintained using a temperature controlled 
cuvette holder.  To ensure good signal to noise, all kinetics data were collected such 
that at least 10,000 counts were achieved in the highest channel for each polarization.  
Our instrument response time is ~150 ps and uncertainty in r0 is ~0.02.  Steady-state 
fluorescence spectra were measured before and after time-resolved anisotropy 
experiments to verify minimal photodamage.  Anisotropy decays were analyzed 
according to the following equation,  
)/()( ctoertr
φ−=       (4.2) 
where ro is the apparent anisotropy at t = 0 and φc is the rotational correlation time 
resulting from depolarization. 
4.2.8  Peptide-membrane Equilibrium 
α-Syn peptide and F4W membrane binding data were modeled according to 
the following two-state equilibrium, a partitioning of the polypeptide between the free 












K =       (4.3) 
where Pf and Pb are the free and bound protein states, respectively, 
app
pK  is the 
apparent partition constant, bpx  is the mole fraction of bound protein, and 
f
pc  is the 








x =  where bpc  is the total bound protein and 
o
Lc  is the total lipid concentration.  
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, eq. 4.4 can be 














λ       (4.5), 







λ       (4.6). 
 Here, Ii and λi are the emission intensity and wavelength, respectively, for i = 325 – 
400 nm.  To account for the fact that only lipids in the outer monolayer are available 
for protein association, apppK  is replaced by 
app
pK6.0 .  Data fitting was performed 
using IGOR Pro (Wavemetrics).  Gibbs free energy was calculated according to: 
)5.55ln( apppKRTG −=Δ       (4.7), 
where 55.5 is the molarity of water.  
4.3  Results and Discussion 
4.3.1  Membrane Affinities and Gibbs Free Energies for N-terminal Peptides and 




The amino acid sequence of P15 (MDVWMKGLSKAKEGV) contains three 
lysine residues, as well as one of seven imperfect amphipathic amino acids repeats 
(KXKEGV) that are reminiscent of amphipathic sequences found in membrane 
binding exchangeable apoPs.83,178  The propensity for the isolated P15 polypeptide to 
associate and to adopt α-helical secondary structure upon membrane interaction can 
be rationalized by the preference of lysine residues (K6, K10, and K12) to flank the 
anionic PA headgroups creating an interface between water-exposed, charged 
residues (D2 and E13) and lipid-facing, nonpolar residues (V3, W4, G7, L8, A11, and 
V14).  Indeed, N-terminal α-syn residues 6 – 15 are predicted by NMR chemical shift 
mapping to have a preference for α-helical formation.140  The shorter peptides 
studied, P4, P6, and P10, contain zero, one, and two lysines, respectively.  Though 
P10 is predicted to form an α-helix based on primary structure analysis,179 P4 and P6 
do not.  Regardless of the exact conformations adopted, herein we assess the 
probability of these peptides to partition into the bilayer. 
To address the possibility that N-terminal residues could serve as membrane 
anchors, we compared the fluorescence properties from single Trp (W4) containing 
N-terminal α-syn peptides (P4, P6, P10, and P15) as a function of varying 
concentrations of phospholipid vesicles (0 – 2.5 mM POPA:POPC in 10 mM NaPi, 
100 mM NaCl buffer at pH 7.4) to that of the full length protein (F4W) (Figure 4.2).  
W4 is an excellent probe of protein-bilayer interactions because not only is the indole 
side-chain exquisitely responsive to local environment and conformation,153,154,156,157 
but has been established as a high affinity membrane binding site in the full length 




Figure 4.2  Comparison of vesicle binding of single Trp containing full-length α-syn 
(F4W) and N-terminal peptides. Mean wavelength (<λ>) as a function of lipid-to-
protein ratio (5 μM α-syn polypeptides, 0 – 3 mM 1:1 POPA:POPC in 10 mM NaPi, 
100 mM NaCl buffer, pH 7.4, 25 °C) for F4W (black) and α-syn residues 1 – 15 (P15; 
blue), 1 – 10 (P10; orange), 1 – 6 (P6; green) fragments.  Fits to membrane partition 
equilibrium model are shown as solid lines.  
 
Prior to vesicle addition, the steady-state fluorescence spectra for all peptides 
and the full-length protein (5 μM polypeptide in 10 mM NaPi, 100 mM NaCl buffer 
at pH 7.4) are similar with mean wavelengths (<λ>) consistent with a water-exposed 
Trp side-chain (<λ> = 361 nm; for the model complex, NATA, <λ> = 365 nm).  
However, in the presence of vesicles, spectral changes are observed as a function of 
polypeptide length reflecting different environments for the W4 side-chain (Figure 
4.2).  Specifically, for P6, P10, and P15, increases in integrated intensity (I) and 
spectral blue shifts (P15 > P10 > P6) suggest increased side-chain rigidity as W4 
interacts with the hydrophobic membrane interior (Table 4.1).  In contrast, even in the 
presence of high vesicle concentrations (2.5 mM POPA:POPC), no significant change 
in mean wavelength (<λ> = 361 nm) or integrated intensity were observed in the P4 
peptide indicating minimal deviations in the W4 microenvironment.  Changes in I 
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full length protein (~2.0 fold increase, 22 nm blue shift) highlighting that the 
association of the first 15 residues result in similar W4 microenvironments for the 
two polypeptides.  
Table 4.1  Steady-state Trp4 spectral and equilibrium vesicle binding properties for 
full-length and N-terminal α-syn peptides. 
 






app  (M-1)e ΔG 
(kcal/mol)f 
P4 NA 363 365 1.0 n.d. n.d. 
P6 NA 361 359 1.2 600 –6.3 
P10 < 15% 361 351 1.9 2900 –7.1 
P15 ~56% 360 343 1.7 3600 –7.2 
Full length 
(F4W) 
~67%102 360 338 1.9 4100 –7.3 
 
a Percent α-helical content at vesicle saturation was determined from circular dichroism (mean residue 
ellipticity at 222 nm ([Θ]222nm)) of polypeptides (10 μM in 10 mM NaPi, 100 mM NaCl buffer at pH 
7.4).  For P10, saturating α-helical content was approximated from [Θ]222nm at high vesicle 
concentration (2 mM).  For P15, [Θ]222nm lipid titrations were fit according to membrane-partition 
equilibrium (eq. 4.3) to determine the percent α-helical content at vesicle saturation.  Mulitple 
independent measurements of [Θ] for polypeptides (n ≥ 2) were compared to ensure reproducibility.  
For example, at a lipid-to-protein ratio of 75, [Θ]222nm for P15 is –6290 deg cm2 dmol–1 with a standard 
deviation of  ±10 (n = 2).  
 
b Steady-state W4 fluorescence mean wavelength (<λ>) for polypeptides (5 μM in 10 mM NaPi, 100 
mM NaCl buffer at pH 7.4). <λ> was determined according to the eq. 4.6.  Error in <λ> due to 
instrument fluctuations is estimated to be  ± 1 nm.  
 
c <λ> for polypeptides in the presence of 1:1 POPA:POPC vesicles (5 μM peptide and 3 mM 1:1 
POPA:POPC in 10 mM NaPi, 100 mM NaCl buffer at pH 7.4). 





I = , where lipidI  and 
aqueousI  
are the integrated steady state emission spectrum (325 – 400 nm) of α-syn polypeptides in the 
presence of vesicles (3 mM 1:1 POPA:POPC) and in buffer (5 μM in 10 mM NaPi, 100 mM NaCl 
buffer at pH 7.4), respectively.  
 
e Apparent membrane partition constants (Kp
app, M-1) extracted from fits to steady-state fluorescence 
data using eq. 4.5.  Fitting error in Kp
app is estimated to be ~500 M-1.    
 
f Gibbs free energies (ΔG) is calculated using eq. 4.7.  Propagated error in ΔG (kcal/mol) is ± 0.1 for 
F4W, P15, and P10 and ± 0.5 for P6.   
 
Using <λ> data, we applied a membrane partition equilibrium model180 to 
extract apparent membrane partition constants ( apppK ) and Gibbs free energies (ΔG) 
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for F4W and N-terminal α-syn peptides (Table 4.1).  Despite differences in absolute 
<λ>, reflecting variations in W4 microenvironments, both apppK  and ΔG values for 
both P10 and P15 were quite similar to that of the full length protein ( apppK  = 4100, 
3600, and 2900 M-1; ΔG = −7.3, −7.2, and −7.1 kcal/mol for full length α-syn, P15, 
and P10, respectively).  However, in the case of P6, we observe substantial decreases 
in apppK  and ΔG (600 M
-1 and −6.3 kcal/mol).  In general, the measured free energies 
for all variants are comparable to those of membrane associating peptides (~ −2.3 to 
−8.9 kcal/mol).180  While the ΔG difference for P6 and P10 (ΔG (P6→P10) = −0.8) is 
consistent with the addition of one lysine in P10 (contributes approximately −1 
kcal/mol due to favorable electrostatic sidechain-head group interactions),181 the 
difference between P10 and P15 is very small (ΔG (P10 → P15) = −0.1 kcal/mol) 
even though P15 also contains one extra lysine.  Moreover, ΔG of P15 is comparable 
to that of the full length protein (ΔG (P15 → F4W) = −0.1 kcal/mol).   
To examine the possible effect of secondary structure formation (i.e. random 
coil  α-helix) on free energy differences, CD spectra were collected for the P10 and 
P15 peptides in the absence and presence of varying concentration of lipid vesicles 
(10 μM polypeptide and 0 – 2.5 mM POPA:POPC in 10 mM NaPi, 100 mM NaCl 
buffer at pH 7.4).  Interestingly, at saturating vesicle concentrations, less than 15% α-
helical content is present for P10 as compared to ~56% in the case of P15 (Figure 
4.3).  It is plausible that enhancement in ΔG resulting from the addition of K12 in P15 
is counterbalanced by some losses in entropy resulting from helical structural 
formation.  Moreover, a similar ΔG value for P15 and the full length protein indicate 
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that the individual amphipathic repeats (there are seven in total) can act as 
independent binding sites and one repeat alone may provide enough stabilization for 
membrane association.  This suggestion is supported by work demonstrating that 
other, isolated α-syn polypeptides can indeed also bind to membranes.114,176  
Regardless of the exact contributions to free energy changes, the CD results 
demonstrate the importance of the full amphipathic repeat sequence, KAKEGV, in α-
helical formation.  Using CD data, apppK  values were determined for P15 and the full-
length protein ( apppK  = 1600 M
-1 and 2000 M-1,
 respectively).  These apppK  values are 
a factor of two smaller than those extracted from fluorescence data, indicating that 
Trp4 partitions into the bilayer prior to the development of secondary structure. 
 
Figure 4.3  Vesicle induced secondary structural formation of P10 and P15 peptides.  
Circular dichroism spectra for P10 (top) and P15 (bottom) (10 μM peptide, 10 mM 
NaPi, 100 mM NaCl buffer, pH 7.4, 25 °C) as a function vesicle addition (0 – 1.25 
mM 1:1 POPA:POPC).  (Inset) The P15 membrane binding curve generated from 
mean residue ellipticity ([Θ]) at 222 nm. The fit to membrane partition equilibrium 









































Though previous work demonstrate that the W4 mutation does not modulate 
membrane induced secondary structural formation in full length α-syn,102 to ensure 
that the mutation also had a minimal effect in the case of the shorter peptides, 
additional CD experiments were conducted.  Figure 4.4 shows the CD spectra for the 
P15 peptide (red) as well 1 – 15 wild type peptide (black) in the absence and presence 
of varying concentrations of vesicles (10 μM peptide alone and in the presence of 0.2 
and 0.5 mM 1:1 POPA:POPC vesicles in 10 mM NaPi, 100 mM NaCl buffer at pH 
7.4).  It is clear that both peptides indeed bind membranes as evidenced by increases 
in α-helical content in the presence of vesicles.  Moreover, analogous 1D 1H NMR 
experiments were also performed and confirm that the presence of the W4 does not 
perturb membrane binding properties (data not shown).   
 
Figure 4.4  Comparison of vesicle induced secondary structural formation in the P15 
and 1 – 15 wild-type peptides.  Circular dichroism spectra for P15 (red) and the 1 -15 
wild-type peptide (black) (10 μM peptide, 10 mM NaPi, 100 mM NaCl buffer, pH 


































4.3.2  Tryptophan Microenvironment at the Bilayer Interface 
Further insights into Trp side-chain mobility and vesicle association as a 
function of polypeptide length were gained through time-resolved anisotropy 
experiments.  In the absence of vesicles, all α-syn peptides and F4W (5 μM 
polypeptide in 10 mM NaPi, 100 mM NaCl buffer at pH 7.4) exhibit small initial 
anisotropies (ro = 0.03 – 0.06, instrument response time ~150 ps) with ns rotational 
correlation times (φC = 0.5 – 0.9 ns) and zero residual anisotropy (r∞) (Figure 4.5).  
These values are consistent with a solvent-exposed and freely rotating Trp side-chain.  
Upon vesicle addition (1.5 mM POPA:POPC), all peptides and F4W show significant 
increases in ro, r∞, and φC, indicative of peptide-vesicle interaction and restriction in 
rotational freedom of W4 upon membrane association.  In the presence of vesicles, ro 
was greatest for F4W, followed by P15, P10, P6, and P4 (0.16, 0.14, 0.14, 0.11, and 
0.09, respectively).  Minimal decay from ro was observed on the timescale of F4W 
fluorescence lifetime in the presence of vesicles (<τ> = 3.6 ns102).  
 
Figure 4.5  Effect of phospholipid vesicles on W4 time-resolved anisotropy of F4W 
and N-terminal peptides.  Time-resolved anisotropy decays for F4W (black) and α-
syn residues, 1 – 15 (P15; blue), 1 – 10 (P10; orange), 1 – 6 (P6; green), and 1 – 4 
(P4; red)  in the absence and presence of phospholipid vesicles (5 μM α-syn 
polypeptides, 0 and 1.5 mM 1:1 POPA:POPC in 10 mM NaPi, 100 mM NaCl buffer, 
pH 7.4, 25 °C).  Data represent the average of n ≥ 3 measurements.  Single 





















While anisotropy data are in accord with steady-state fluorescence results 
indicating the membrane association of F4W, P15, P10, and P6, they reveal that P4 
also is interacting with the vesicles.  Particularly, increases in ro and r∞ upon vesicle 
addition show that P4 is part of a larger, vesicle-bound complex that has a slower 
tumbling time than P4 alone in solution.  It is possible that a steady-state spectral shift 
was not observed because though P4 is bound, Trp4 does not embed into the 
hydrophobic environment of hydrocarbon chain. Furthermore, the expected increase 
in intensity upon restriction of the indole rotational motion could be offset by the 
fluorophore being in close proximity of the negatively charged head groups which 
would lead to a quantum yield decrease.52  
4.3.3  N-terminal Peptide Membrane Binding Probed by 1-Dimensional 1H 
Nuclear Magnetic Resonance 
1D 1H NMR experiments were performed on P4, P6, P10, and P15 to evaluate 
the participation of all polypeptide residues in membrane association.  Figure 4.6 
shows the 1D 1H NMR data for polypeptide alone (10 μM peptide, 10 mM NaPi, 100 
mM NaCl, pH 7.4; 2.6% D2O) and upon the addition of vesicles (lipid-to-protein 
molar ratio of 300, 3 mM POPA:POPC).  All spectra of free peptides show 
characteristic tryptophan peaks in both the 7 – 7.75 ppm region (N-H bond) and 
around 10.1 ppm (aromatic H).  We note that C-terminal amidation of the peptides 




Figure 4.6  1D 1H NMR spectra of N-terminal α-syn peptides.  (Top-to-Bottom) 
NMR spectra for α-synuclein polypeptides, P4, P6, P10, and P15 for peptides alone 
(red) (10 μM peptide, 10 mM NaPi, 100 mM NaCl, pH 7.4; 2.6% D2O) and upon the 
addition of vesicles (blue) (lipid-to-protein molar ratio of 300, 3 mM POPA:POPC).  
The sharp peak denoted by an asterisk at 8.37 ppm observed in some of the lipid-
containing samples is attributable to a phospholipid contaminant.  The intensity of 
Trp aromatic H region has been expanded for clarity. 
 
Polypeptide length dependent changes in the NMR spectra are clearly 





















shifts change upon the addition of vesicles, demonstrating that indeed this peptide is 
vesicle-bound.  The largest differences in peak heights are in the amide region 
indicative of association of the P4 peptide-backbones with the vesicles.  Though it is 
evident that P4 is bound, observed changes are markedly reduced as compared to the 
other peptides, a result consistent with steady-state fluorescence data.  In the case of 
P6, the whole spectrum is noticeably affected by the presence of vesicles.  The 
broadening and shifting of all peaks suggest that the interaction is occurring in the 
fast-exchange regime and likely at all peptide sites.  Similar, yet more pronounced, 
trends are observed for P10 and P15, with peaks broadened and disappearing upon 
vesicle binding.  While it is difficult to definitively verify fast exchange for P15 due 
to poor signal-to-noise, our data indicate that P15 has a higher affinity for vesicles 
than P10. 
4.3.4  Trp4 side-chain Bilayer Penetration 
It is well established that the penetration of Trp residues into a lipid bilayer 
can be monitored via fluorescence quenching by molecules such as nitroxide or 
bromine that are incorporated at specific sites in the lipid hydrocarbon chain.53-56  To 
directly probe α-syn polypeptide-hydrocarbon interactions, we incorporated 
brominated lipids into vesicles and measured Trp fluorescence upon addition of F4W 
and single Trp containing α-syn fragments.  We compared the steady-state 
fluorescence of W4 containing polypeptides in the absence and presence of vesicles 
containing 30% di-bromine-labeled POPC lipids at different sites in the fatty acid 
chain (5 μM polypeptide and 1.5 mM POPA:POPC vesicles in 10 mM NaPi, 100 mM 
NaCl buffer at pH 7.4).  Figure 4.7A shows representative steady-state and time-
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resolved fluorescence data for P15 in the presence of 1:1 POPA:POPC vesicles (blue) 
and 1:1 POPA:POPC vesicles containing 30% Br6-7PC (light blue).  Relative 
quenching was comparable using both methods.  Since fluorescence quenching will 
occur only when Trp is in close proximity (van der Waals contact) to a bromine,53 
insertion depths into the membrane can be estimated by using lipids labeled with 
bromine at different acyl-chain positions (Br6-7PC, Br9-10PC, and Br11-12PC 
correspond to ~ 11 Å, 8.3 Å, and 6 Å above the bilayer center, respectively,182 Figure 
4.7B).   
The comparison of steady-state W4 fluorescence quenching from vesicles 
containing brominated lipids (IBr) to unlabeled POPA:POPC vesicles (ILipid) for F4W 
and the P15, P10, P6, and P4 peptides is provided in Figure 4.7C.  Consistent with 
steady-state Trp fluorescence measurements, the P4 peptide fluorescence exhibits no 
significant quenching at all sites tested.  While not precluding headgroup interactions, 
these data confirm that the Trp4 side-chain in P4 is not penetrating into the bilayer 
hydrocarbon core.  In the presence of brominated lipids, decreases in P6 fluorescence 
are modest yet measurable (IBr/ILipid = 0.93 – 0.99), indicating that at least a small 
fraction of membrane-bound P6 embeds into the hydrocarbon chain region.  In 
contrast, with the addition of four more residues, including a lysine at position 10, 
substantial decreases in P10 Trp intensity are observed for all bromine positions.  
Though quenching at all bromine positions was observed (~ 6 – 11 Å above bilayer 
center), there is a predominance of conformations in which Trp4 is closer to the head 
group region as evidenced by modest increases in quenching: Br6-7PC > Br9-10PC > 






Figure 4.7  Tryptophan side-chain penetration into the vesicle bilayer.  (a) Steady-
state (left) and time-resolved (right) fluorescence of the P15 α-syn peptide (5 μM in 
10 mM NaPi, 100 mM NaCl buffer, pH 7.4, 25 °C) in the presence of 1:1 
POPA:POPC vesicles (dark blue) and 1:1 POPA:POPC vesicles containing 30% 
bromine-labeled Br6-7PC lipids (light blue) (5 μM in 10 mM NaPi, 100 mM NaCl 
buffer, pH 7.4, 25 °C, lipid-to-protein molar ratio of 300).  (b) Structure of PC 
phospholipid with positions of bromines highlighted.  (c) Relative quenching of W4 
steady-state fluorescence for F4W and N-terminal peptides (5 μM in 10 mM NaPi, 
100 mM NaCl buffer, pH 7.4, 25 °C) in the presence of 1:1 POPA:POPC vesicles 
containing 30% Br6-7PC, Br9-10PC, and Br11-12PC (1.5 mM total lipid). Relative 
quenching is reported as IBr / ILipid, where IBr and ILipid is the integrated steady-state 
emission (325 – 400 nm) in the presence of vesicles containing and not containing 
brominated lipids, respectively. Error bars represent standard deviations (n ≥ 3). 
 
Similarly to P10, both P15 and the full-length protein exhibit significant 
quenching upon addition of brominated phospholipids.  Though quenching is still 
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greatest in the presence of Br6-7PC (IBr/ILipid = 0.58 ± 0.01, 0.53 ± 0.05, for P15 and 
F4W, respectively), comparable quenching was observed in the presence of Br9-10 
(IBr/ILipid = 0.58 ± 0.03, 0.54 ± 0.01, for P15 and F4W, respectively).  Moreover, 
substantial quenching was also observed in the presence of Br11-12PC (IBr/ILipid = 0.67 
± 0.05, 0.60 ± 0.01, for P15 and F4W, respectively).  These data highlight the 
importance of lysine residues in promoting peptide penetration into the membrane 
hydrocarbon region (full length > P15 > P10 >> P6 > P4).  Taken together, our 
fluorescence and CD data demonstrate that the α-helical forming P15 could serve as a 
minimal model for N-terminal interactions as it nearly captures the properties of the 
full length protein. 
4.4  Summary 
Using multiple experimental methodologies, we have investigated the 
participation of specific N-terminal α-syn residues through the use of single Trp 
containing synthetic peptides.  By comparing various spectroscopic properties of 
F4W to that of synthetic peptides, we find that the addition of lysine residues 
enhances membrane binding affinity (full length > P15 > P10 > P6 >> P4) and that at 
least one imperfect amphipathic repeat sequence (KAKEGV) is required for α-helical 
formation.  While fluorescence spectral features of P4 do not indicate membrane 
association, both time-resolved anisotropy and 1D 1H NMR reveal that indeed P4 can 
bind to vesicles albeit with much lower affinity compared to the other peptides.  
Time-resolved anisotropy and fluorescence quenching by brominated lipids further 
demonstrate that the molecular mobility and insertion of the Trp4 side-chain into the 
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bilayer, respectively, are also peptide length dependent with P15 nearly recapitulating 
the features of the full-length protein.   
Our finding that the minimal sequence required for α-syn-membrane 
association is within the N-terminal fifteen residues could be of biological relevance.  
Because the surface of synaptic vesicles is crowded with numerous integral and 
peripheral membrane proteins, the lipid availability is greatly reduced and even 
considered “hardly visible”;183 it is likely that α-syn would not be able to bind in a 
fully extended (residues 1 – 100) α-helical conformation as is the case of the α-syn-
synthetic vesicle binding in vitro.  The possible binding of an isolated N-terminal 
sequence of α-syn in vivo is further supported by recent work demonstrating that 
deletion of even one N-terminal amino acid can significantly enhance cell viability.177  
Moreover, the association of α-syn at the far N-terminus would allow for interactions 
with other biomolecules at more central and C-terminal protein sites.  For example, it 
has been suggested that α-syn promotes SNARE complex assembly via N-terminal 
membrane association and C-terminal interaction with the SNARE protein, 
synaptobrevin.94  Another recent example is the proposal that α-syn can interact with 
glucocerebrosidase in the lysosome where the N-terminal portion of the polypeptide 
is membrane bound and via its C-terminal tail associates with the enzyme.184  
Considering these recent works, future experiments using P15 as a minimal model of 
α-syn-phospholipid interaction site and natural membranes such as synaptic vesicles 
will allow us to gain residue level insights into its biological function.  
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Chapter 5:  Structure of the α-Synuclein Membrane 
Interface:  Insights from Neutron Reflectometry* 
 
 
5.1  Introduction 
Similar to electrons or x-rays, the interaction of neutrons with a material can 
provide pertinent structural information.  Neutrons are particularly well suited for the 
study of biological materials because, unlike electrons and x-rays, neutrons have 
highly disparate scattering length densities (nSLD) for hydrogen and its isotope 
deuterium with de Broglie wavelengths on a molecular length scale (~5 Å).63  Thus, 
organic interface layers which contain different number of hydrogen atoms, such as 
the lipid head groups and hydrocarbons in a bilayer lipid membrane, can be readily 
distinguished using neutron reflectometry (NR).     
In this chapter, results from experiments employing NR and a surface-
stabilized sparsely tethered bilayer lipid membrane (stBLM)64,185 to examine α-syn 
membrane interactions are presented.  Though membrane-bound α-syn has been the 
focus of substantial research efforts due to its likely involvement in PD 
pathogenesis,40,186 unlike other approaches, NR experiments provide the unique 
opportunity to simultaneously measure both membrane-bound protein structure as 
well as protein induced changes in membrane properties.  Moreover, while 
oligomeric and fibrillar forms of α-syn have been shown to induce membrane 
                                                 
* Research was performed in part at the National Institute of Standards and Technology Center (NIST) 
for Nanoscale Science and Technology.  Thanks to Frank Heinrich for overseeing neuron data 
collection and for performing data analysis, Grzegorz Piszczek (Biophysics Facility, NHLBI), Duck-
Yeon Lee (Biochemistry Core Facility, NHLBI), and Ephrem Tekle (Laboratory of Biochemisty, 
NHLBI) for technical assistance, Thai Leong Yap for providing the dye labeled α-synuclein, and D. J. 
Vanderah (NIST) for synthesizing the HC18 tether molecule. 
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perturbations and even pore formation,184 the high sensitivity of NR facilitates 
measurement of the effects of monomeric α-syn on membrane structure.  
Using a stBLM composed of 1:1 molar ratio of 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphate (POPA) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) and NR, we find that α-syn associates with the membrane at both the head 
group and hydrocarbon chain region, extends into the bulk solvent, and also induces 
membrane thinning.  In addition, NR was employed to elucidate the effects of α-syn 
concentration on protein and membrane structure.  In these experiments, uniformly 
deuterated α-syn protein was used to ensure greatest contrast between the protein and 
the bilayer.  Upon addition of different concentrations of α-syn, changes in protein 
volume occupancy in the headgroup/hydrocarbon and bulk solvent regions as well as 
degree of membrane thinning were observed.  These results may be of physiological 
relevance because α-syn gene triplication72 and duplication73 are linked to early onset 
PD and changing lipid-to-protein stoichiometry modulates α-syn aggregation kinetics 
in vitro.   
5.2  Materials and Methods 
5.2.1  Materials 
Phospholipids (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (POPA) and 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)) were purchased from 
Avanti Polar Lipids (Alabaster, AL) and used as received.  N-acetyl-tryptophanamide 
(NATA) and β-mercaptoethanol (β-ME) were obtained from Sigma-Aldrich (St. 
Louis, MO).  D2O was purchased from Cambridge Isotopes Laboratory (Andover, 
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MA) and tetramethylrhodamine-5-maleimide from Invitrogen. Polished [100]-Si 
wafers (75 mm in diameter) were obtained from EL-CAT Inc. (Waldwick, NJ).   
5.2.2  Recombinant Protein Expression, Purification, and Labeling 
Wild-type (WT), F4W, F94W, and A90C α-synucleins were expressed and 
purified as previously reported.102  For A90C, all lysis and purification buffers also 
contained 0.5 mM dithiothreitol (DTT) to prevent disulfide bond formation.  
Uniformly deuterated WT α-syn was expressed and purified according to previously 
reported procedures102 with minor modification.  Cell pellet from 1 mL of starter 
culture in Lauria Broth (LB) was resuspended in 20 mL minimal media187 and 
incubated (30 °C, 165 RPM) overnight.  Cell pellet was subsequently resuspended in 
D2O based minimal media supplemented with d-glucose (1 g/L) and d-celtone (3 g/L) 
(Cambridge Isotope Laboratories, Inc.).  Large growths (2.7 L total) were induced 
with IPTG (1 mM) and cells harvested after ~6 h.  Uniformly deuterated α-syn was 
purified according to published methods.102   
Protein concentration was determined using a molar extinction coefficient 
estimated on the basis of amino-acid content: ε280 nm = 5,120 M−1cm−1 (WT, A90C) 
and ε280 nm = 10,810 M−1cm−1 (F4W, F94W).   The purity of protein samples was 
assessed by SDS-PAGE on a Pharmacia Phastsystem (Amersham Biosciences) and 
visualized by silver-staining methods.  The protein molecular weights were confirmed 
by ESI-MS (Biochemistry Core Facility, NHLBI).  All purified proteins were 
concentrated using a YM-3 filter (MWCO 3kD, Millipore) and stored at −80 °C.  For 
uniformly deuterated α-syn, a molecular weight of 15,472 was measured reflecting 
~76% deuteration of available hydrogen.     
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Tetramethylrhodamine (Rho) A90C α-syn (A90C-Rho) was labeled and 
purified according to published protocol184 with minor modification.  A stock of Rho 
dye in dimethyl-sulfoxide was prepared and Rho labeled protein concentration 
determined using an ε511 nm = 90,000 M−1cm−1.   
5.2.3  Phospholipid Vesicle Preparation  
Phospholipid vesicles were made from a 1:1 molar ratio of POPA and POPC.  
Chloroform solutions of 1:1 POPA and POPC were dried under a nitrogen stream for 
20 min followed by vacuum desiccation for 45 min to ensure complete removal of 
organic solvent.  Dried samples were then resuspended in 10 mM NaPi, 100 mM 
NaCl buffer, pH 7.4 to a final concentration of 5 mg/mL by bath sonication for 5 – 10 
min.  Vesicles were prepared via ultrasonication in a water bath (45 minutes, 50% 
duty cycle, microtip limit, Branson 450 Sonifier).  Vesicle solutions were diluted to a 
final concentration of 2.5 mg/mL, equilibrated overnight (14 – 24 h) at 37 °C, and 
prepared freshly for each experiment.  Average vesicle hydrodynamic radius was 
determined to be 45 – 55 nm by dynamic light scattering (Wyatt DynaPro NanoStar; 
fifty 5 s acquisitions, 25 °C).   
5.2.4  Steady-state Spectroscopic Measurements 
Spectroscopic measurements were made as follows: absorption, Cary 300 Bio 
spectrophotometer; CD, Jasco J-715 spectropolarimeter (200 – 260, 1 nm steps, 1 nm 
bandwidth, 0.5 s integration time, and 50 nm/min, 1 mm cuvette pathlength), and 
luminescence, Fluorolog-3 spectrofluorimeter (λex = 295 nm, λobs = 300 – 500 nm, 
0.25 s integration time, 1 and 2 nm excitation and emission slit widths, respectively).  
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All measurements were collected at 25 °C using temperature controlled cuvette 
holders except for absorbance experiments.  For all spectra measured in the presence 
of vesicles, background scans were collected and subtracted.  Prior to experiments, all  
α-synucleins were exchanged into 10 mM NaPi, 100 mM NaCl, pH 7.4 buffer using a 
PD-10 column (GE Healthcare).  All protein solutions containing vesicles were 
incubated for at least 30 min at RT prior to measurement.   




][ =Θ  where θ  is the measured ellipticity (mdeg), c is the sample 
concentration (mM), l is the path length (cm), and N is the number of amino acids.  




−Θ nm .  
Reference values of [Θ]222 nm = 0 and −36,000 (deg cm2 dmol-1) were used for 0% and 
100% helicity respectively.161   
5.2.5  Preparation of Sparsely Tethered-lipid Bilayer Membranes for Neutron 
Reflectometry  
 Polished silicon wafers were coated with Cr adhesion layers (≈20 Å) and Au 
films (≈150 Å) by magnetron sputtering (Auto A306; BOC Edwards, UK, and Denton 
Discovery 550, Denton Vacuum, LLC, USA).  A self-assembled monolayer (SAM) 
comprised of the lipid tether compound HC18 (Z20-(Z-octadec-9-enyloxy)-
3,6,9,12,15,18,22-heptaoxatetracont-31-ene-1-thiol) was produced by immersing the 
Au-coated wafers in ethanolic solutions of HC18 and βME (20:80 molar ratio, 0.2 
mM final concentration).64  After incubation (> 12 h) the wafers were thoroughly 
rinsed with absolute ethanol and dried under nitrogen. 
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 Sparsely tethered bilayer lipid membranes (stBLM) were then formed by the 
rapid solvent exchange (RSE) procedure described elsewhere.64  Briefly, the Si-wafer 
containing the SAM was assembled in a flow cell designed at the NIST Center for 
Neutron Research (Gaithersburg, MD).   Stocks of lyophilized phospholipids were 
dissolved to 10 mg/mL (POPA in 95% methanol, 4% H2O, and 1% chloroform; 
POPC in methanol) and mixed to a 1:1 molar ratio.  The organic solution of 
phospholipid was injected into the flow cell and allowed to incubate for 10 min at RT.  
Finally, RSE was performed to complete stBLM formation process.  For all 
reflectivity measurements, the stBLM was kept immersed in aqueous buffer solution 
(10 mM NaPi, 100 mM NaCl, pH 7.4). 
5.2.6  Neutron Reflectivity Measurements 
Neutron reflectivity measurements were performed at the NG1 reflectometer 
at the NIST Center for Neutron Research (NCNR).188  A momentum transfer, qz, 
range between 0 and at least 0.25 Å–1 was used for all measurements.  The stBLM 
was first measured in aqueous buffer (10 mM NaPi, 100 mM NaCl, pH 7.4) 
containing three isotopically different compositions (100% D2O, 100% H2O, and 2:1 
H2O:D2O). Then, the stBLM was measured in the presence of aqueous buffers 
containing α-syn (3 μM in 10 mM NaPi, 100 mM NaCl, pH 7.4, 100% H2O or 100% 
D2O).  For each solution condition (contrast), adequate counting statistics were 
obtained after 6 – 9 h.  The flow cell design allows for in situ isotopic solvent contrast 
exchange; therefore, subsequent measurements were performed on the same sample 
area. The entire flow cell was maintained at RT. 
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5.2.7  Neutron Reflectometry Data Analysis  
The neutron scattering length density (nSLD) profile is modeled using a 
combination of a box model for the solid substrate and a composition space model189 
for the stBLM and the peptide.  The composition space model describes the surface 
architecture in terms of spatial distributions of sub-molecular groups rather than slabs 
of constant nSLD like in the conventional box model.190  The composition space 
model requires a minimum number of fit parameters, because it incorporates a 
maximum of external information about the system (e.g. chemical connectivity, 
molecular volumes, and scattering lengths).  Individual sub-molecular groups 
implemented in the model are: β-ME, tether PEG chains, tether glycerol groups, 
substrate-proximal and substrate-distal PC and PA headgroups, substrate-proximal 
and substrate-distal hydrocarbon chains of lipid and tether molecules, and the peptide.  
Fit parameters are the bilayer hydrocarbon thickness, bilayer completeness, tether 
surface density, tether thickness, and β-ME surface density.   
The peptide is modeled as two adjacent regions of constant volume 
occupancy.  The interface between the two regions aligns with the substrate-distal 
headgroup interface to the bulk solvent; one region penetrates the lipid bilayer and the 
second region extends into the bulk solvent.  Length and volume occupancy of the 
two regions are separate fit parameters.  Reflectivity is computed using the optical 
matrix method189 after translating the composition space model into a box model 
consisting of slabs of 0.5 Å width and zero roughness.  Data modeling and 
optimization of model parameters was performed using the ga_refl software 
package188 developed at the NCNR.  Optimization of model parameters is achieved 
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by the combined use of a genetic algorithm, a simplex amoeba algorithm for efficient 
searching of parameter space, and a Levenberg-Marquardt non-linear least square 
algorithm to refine the fit.  All reflectivity curves measured on the same wafer during 
the course of an experiment were fitted simultaneously to the same model, sharing fit 
parameters, for example, for the solid substrate.   
An established Monte Carlo error analysis procedure185 was used to determine 
the fit parameter confidence limits by multiple generation of simulated reflectivity 
consistent with the measured data based upon the statistical uncertainties of the 
measured data points.  Simulated reflectivity curves were subsequently fitted to the 
same model.  Using a statistic analysis of the obtained set of parameter values, a bias-
free and objective estimate of the uncertainties of the resulting nSLD profiles is 
obtained. 
5.2.8  Preparation of Supported Bilayer Membranes for Fluorescence 
Correlation Spectroscopy  
Cleaned Lab-Tek eight-well chambered coverglass (Nunc) was used as the 
supported bilayer membrane (SBM) substrate.  Chambers were first cleaned by 
rinsing with filtered and deionized water followed by 70% ethanol and water.  The 
chamber was then submerged in a beaker containing a solution of 2% Hellemax 
(Hellma Analytics) in water.  The beaker was then placed in a pre-heated (50 °C) 
water bath and subjected to three cycles of 5 min sonication followed by 5 min 
incubation.  The coverglass was then rinsed thoroughly with water and shaken to 
remove excess water.  Before drying, a lipid solution (200 μL, 0.1 mM 1:1 
POPA:POPC vesicles, 5 mM CaCl2) was applied to the cleaned chamber.  
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Importantly, the CaCl2 was added to the lipid solution immediately prior to 
application to the cleaned coverglass.  After incubating for 30 min at RT to facilitate 
formation the SBM, the SMB was washed by repeated buffer exchange (10 mM 
NaPi, 100 mM NaCl, pH 7.4) using a micropipette.  During washing, the micropipette 
was never placed closer than 1 mm from the coverglass to avoid any damage to the 
SLB.   
5.2.9  Fluorescence Correlation Spectroscopy   
 Fluorescence Correlation Spectroscopy (FCS) measurements were performed 
using a LSM 5 Pascal microscope (Carl Zeiss) based instrument.  An argon laser (514 
nm) and a 1.3 N.A. 40× Plan-Neofluar objective (Carl Zeiss) were used for sample 
excitation and emission collection, respectively.  In all experiments the excitation 
focal volume was placed in solution above the SLB.  Rho emission was selected 
using a band pass filter (560 – 615 nm) and focused onto an avalanche photodiode 
detector.  Coincidence autocorrelation of data was performed using a PicoHarp 300 
(PicoQuant) in time-tagged T2 mode.  At least five, 20 s acquisitions were made for 
each condition.   
Prior to A90C-Rho measurements, autocorrelation curves (G(τ)) were 
collected for varying concentrations of Rhodamine 6G (5.5 – 50 nM in H2O) to 
determine the excitation focal volume.  Solutions of 500 μL were used for all sample 
measurements and was achieved by filling the coverglass chamber fully (~720 μL) 
and then removing 220 μL.  For α-syn membrane binding concentration experiments, 
autocorrelation curves for A90C-Rho in the absence (15 nM 90C-Rho α-syn, 10 mM 
NaPi, 100 mM NaCl) and presence of WT protein (100 nM  − 5.65 μM, 10 mM NaPi, 
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100 mM NaCl) were collected.  For each set of A90C-Rho data, the same SLB was 
used.  At each concentration, samples were incubated at least 10 min prior to data 
collection.  Membrane binding curves were determined by calculating the average 
number of A90C-Rho proteins in the focal volume according to the equation G(0) = 
1/N, where G(0) is the value of the autocorrelation function at τ = 0 and N is the 
average number of particles in the focal volume.  In these experiments, G(0) was 
measured at 0.01 ms to ensure minimal contributions from inter-molecular processes, 
and triplet formation.191  
5.2.10  Protein-bilayer Membrane Equilibrium 
FCS membrane binding equilibrium data were modeled according to the 
simple law of mass action for identical and independent binding sites.163,164  
Estimation of apparent association constants were extracted according to the 
following two-state equilibria for the WT protein and the A90C-Rho labeled 
synuclein:  
                 ff





K =,       
                   ff





K =,     (5.1) 
where fRho  
and fWT  is the free A90C-Rho and WT α-syn concentration, 
respectively,
 f
B  is the free binding sites, and bRhoB  and bWTB  is the bound A90C-
Rho and WT α-syn concentration (occupied binding sites), respectively.  The total 
binding sites (Bt) is defined as LBmax , where maxB  is the maximum binding sites per 
 86 
 
lipid molecule, and L is the total lipid concentration.  Assuming that the affinity of 
A90C-Rho and WT for the bilayer is equal, appWTa
app
Rhoa KK ,, = , and that 
bft RhoBRhoRho += , bft WTBWTWT += , and LBWTBRhoBBB bbft max=++=  we 


















































N    (5.2) 
where N is the number free A90C-Rho α-syn (which is proportional to fRho ) 
measured in FCS experiments and A is a scalar fitted to correct for the amplitude of 
the data.  The fitting equation was solved for using Mathematic (Wolfram) and fitting 
was performed using IGOR Pro 6.01 (Wavemetrics). 
5.3  Results and Discussion 
5.3.1  Fluorescence Correlation Spectroscopic Characterization of α-Synuclein 
Membrane Binding to a Planar Bilayer Membrane  
While the binding properties of α-syn to phospholipid vesicles of varying size 
and composition have been thoroughly investigated,64,185 to assess binding to a planar 
membrane geometry similar to that used in NR experiments, a supported lipid bilayer 
(SLB) was produced for use in fluorescence correlation spectroscopy (FCS) 
experiments.  In FCS, time-dependent intensity fluctuations resulting from 
fluorescent molecules diffusing in and out of a small focal volume can be measured.59  
Autocorrelation of these fluctuations facilitates determination of diffusion coefficients 
as well as sample concentration.59   
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To generate α-syn SLB binding curves using FCS, autocorrelation curves 
were collected for singly labeled tetramethylrhodamine A90C α-syn (A90C-Rho) 
exposed to the SLB in the absence (15 nM 90C-Rho α-syn, 10 mM NaPi, 100 mM 
NaCl) and presence of WT protein (100 nM − 5.65 μM, 10 mM NaPi, 100 mM 
NaCl).  In these experiments the FCS focal volume was placed in solution above the 
SLB.  A POPA:POPC lipid composition was chosen for the SLB to facilitate 
comparison to our prior work using 1:1 POPA:POPC vesicles102 and because α-syn 
has been demonstrated by numerous groups to have a high affinity for POPA.116,192  
At low α-syn concentrations (15 nM A90C-Rho), most of the proteins are 
bound to the SLB and thus a low concentration is measured in solution.  As non-
fluorescent WT protein is added, bound A90C-Rho proteins exchange with WT 
leading to an increase in A90C-Rho proteins diffusing through the focal volume.  
Figure 5.1 shows the autocorrelation curves (G(τ)) generated for 15 nM 90C-Rho 
(red) and upon addition of  varying concentrations of WT protein (100 nM – 5.65 
μM).  As expected, the amplitude of the (G(τ)) curves decreases as WT protein is 
added while the characteristic diffusion time  (approximately the half amplitude of 
G(τ)191) of the A90C-Rho species in solution remains constant at all concentrations 




Figure 5.1  Fluorescence correlation spectroscopy (FCS) autocorrelation curves 
(G(τ)) for singly labeled tetramethylrhodamine (Rho) A90C α-syn (A90C-Rho) 
exposed to a supported lipid bilayer (1:1 POPA:POPC) in the absence (15 nM A90C-
Rho α-syn, 10 mM NaPi, 100 mM NaCl) and presence of WT protein (100 nM − 5.65 
μM).  (Inset) Number of Rho α-synucleins in FCS focal volume as a function of total 
protein concentration. The fit of the data is shown as a solid line.   
 
The average number of fluorescent proteins diffusing through the focal 
volume, N (N = 1/G(0)) as a function of total protein concentration is shown in the 
inset of Figure 5.1.  Fitting this data using a law of mass action for identical 
independent binding sites yields an apparent association constant ( appaK ) of ~ 2 × 10
7 
M-1.  This value is highly consistent with that previously determined for POPA:POPC 
unilamellar vesicles (~100 nm diameter, appaK
 
~ 1 × 107 M-1),102 reflecting that effects 
due to curvature are minimized in this size regime.     
5.3.2  Neutron Reflectometry as a Dual Probe of α-Synuclein and Membrane 
Structure 
 
To simultaneously probe α-syn and phospholipid bilayer structure neutron 
reflection measurements were performed.64,185,188  Specifically, the neutron reflection 
of a stBLM composed of 1:1 molar ratio of POPA:POPC in the presence and absence 
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of α-syn (3 μM in 10 mM NaPi, 100 mM NaCl) was measured.  A minimum of two 
reflectivity curves were collected for each condition using isotopically different 
solvents (e.g. H2O or D2O based buffer).  Figure 5.2a shows the neutron reflection for 
the stBLM alone and in the presence of α-syn in H2O (red) and D2O (blue) buffers.  
For both solvents, residuals between reflectivity curves with and without peptide 
exceed five standard deviations at low momentum transfer values and average 1 – 3 
standard deviations up to a momentum transfer qz = 0.15 Å
-1.  These significant 
changes in the measured reflectivity upon the addition of protein manifest in a 
modulation of the amplitude and the frequency of the Kiessig fringes.  These fringes 
occur due to the interference of neutrons reflected from each of the different organic 
interface layers and are therefore related to thickness of each layer.  Fits of the data 
based on a composition space model189 (see Materials and Methods) are shown as 
solid lines.  Along with a schematic view of the stBLM, Figure 5.2b shows a cross-
sectional profile of the organic interface extracted from the best fit to the data.  For 
simplicity, a number of sub-molecular groups that were modeled separately have been 





Figure 5.2  Neutron reflection of a sparsely tethered POPA:POPC bilayer lipid 
membrane (stBLM) and changes resulting from the addition of α-syn.  (a) Neutron 
reflectivity (R/RF) for a POPA:POPC stBLM in the absence and presence of α -syn (3 
μM in 10 mM NaPi, 100 mM NaCl, pH 7.4) in H2O and D2O.  Composition space 
model fits to the data are shown as solid lines. Error bars represent the 68% 
confidence intervals for the measured reflectivity based on Poisson statistics.  (b, 
Top) Schematic of stBLM with additional solid substrate portions (Si, SiOx, Cr, and 
Au) partially omitted.  (b, Bottom) Simplified molecular distributions for each of the 
organic interface layers of the POPA:POPC stBLM and α-syn obtained from best-fit 
of reflectivity data to the composition space model.  The dotted line denotes a 
reference value for area per lipid.  Data for Si substrate and the SiOx, Cr, and Au 
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Table 5.1:  Neutron reflectometry fitting parameters for a POPA:POPC stBLM in the 
absence and presence of α-syn (3 μM in 10 mM NaPi, 100 mM NaCl, pH 7.4).  
 
 
a The 68.2% confidence intervals for each fit parameter are designated in super- and subscripts.  
 
b The high density peptide region is located near substrate-distal headgroups and penetrates into the 
hydrocarbon chains of the bilayer. 
 
c The low density region is located above the outer headgroups and describes peptide which is extended 
into the bulk solvent phase. 
 
 
Using a Monte Carlo resampling procedure, bilayer and protein fit parameters 
(layer thickness, neutron scattering length density (nSLD), volume occupancy) and 
the associated 68.2% confidence intervals were computed (Table 5.1).  Prior to 
incubation with protein, substrate and neat bilayer parameters fall within expected 
values with an inner and outer bilayer leaflet thickness of 2.1 2.14.14 −  Å and 
1.1
2.18.14 −  Å, 
PARAMETER NEAT BILAYERa + 3 μM α-SYNUCLEINa 
Solid Substrate 
thickness SiOx  (Å) 21.8+1.0 -1.1  
nSLD SiOx (Å-2) 3.64 × 10-6 (fixed) 
thickness Au (Å) 162.2+0.5-0.4 
nSLD Au (Å-2) 4.51+0.01 -0.01 × 10
-6 
stBLM, Tether Region 
thickness tether (Å) 12.3+0.3-0.4  
number of β-mercaptoethanol 
molecules per tether molecule 
0.79+0.02-0.02 
stBLM, Lipid Bilayer Region 
molar fraction of tether 
hydrocarbon chains in inner 
bilayer leaflet 
0.64+0.10-0.12 
thickness inner bilayer leaflet 
(Å) 
14.4+1.2-1.2  Change:  -0.72
+0.20
-0.24  
thickness outer bilayer leaflet 
(Å) 
14.8 +1.1-1.0  Change:  -0.72
+0.20
-0.24  
bilayer completeness 0.95+0.01-0.01 1.00
+0.01
-0.01 
Peptide, High Density Regionb 
thickness (Å) NA 13.1 +7.6-3.4  
penetration into the 
hydrocarbon region  (Å)    
NA 4.2+5.5-2.2  
volume occupancy of peptide NA 0.15+0.12-0.09 
Peptide, Low Density Regionc 
thickness (Å)  NA 63.1+4.7-5.0   
volume occupancy of peptide NA 0.068+0.008-0.009 
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respectively.  Upon protein addition, reflectivity data indicate that substantial α-syn (
%15129−  volume occupancy) is associating with the membrane at both the head group 
and hydrocarbon region ( 6.7 4.31.13 −  Å thick protein region penetrating 
5.5
0.22.4 −  Å into the 
outerleaflet hydrocarbons).  α-Syn ( %8.6 8.0 9.0−  volume occupancy) was also found to 
extend well into the bulk solvent region ( 7.4 0.51.63 −  Å).  The association of α-syn also 
resulted in sizable reduction ( 40.0 48.044.1 −  Å) in membrane bilayer thickness. 
Though exact protein conformation(s) cannot be determined, neutron 
reflectivity data are consistent with a scenario in which α-syn is anchored to the 
membrane by key interaction sites leaving other protein regions solvent exposed.  
Moreover, given the thickness of the high density protein region situated in the 
headgroups and hydrocarbons (~ 6.7 4.31.13 −  Å), it is plausible that membrane associated 
α-syn is in an α-helical conformation.  These data support recent NMR results39 in 
that N-terminal residues could be associated to the membrane while more central and 
C-terminal residues remain solvent accessible.  Surprisingly, though α-syn has been 
implicated as a membrane curvature sensor, in which tighter binding is observed in 
the presence of smaller, more highly curved phospholipid vesicles,116 we find α-syn 
has a relatively high surface coverage (~15% at the head group and hydrocarbon 
region) in the presence of 3 μM protein as compared to previous work employing 
lipid vesicles (average diameter 80 nm, ~7%) of identical phospholipid 
composition.102  It is plausible that due to the larger size of the vesicles used, 
curvature effects are attenuated as has been observed in a recent study on the effect of 
membrane curvature on α-syn membrane binding.192 
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 The observation that bilayer thickness is reduced upon α-syn association is 
intriguing because protein induced membrane perturbations have been linked to 
disease pathology.125-128  Specifically, it was shown that protofibrillar α-syn can 
induce transient permeabilization in anionic membranes and thus may be related to 
cell toxicity and disease by altering the calcium flux into the cytosol, depolarization 
of mitochondrial membranes, and/or leakage of intra-vesicular neurotransmitter 
molecules, such as dopamine.129  Numerous subsequent in vitro studies corroborate a 
possible role for α-syn in membrane perturbation and/or permeabilization.119,130-136  
Notably, though membrane perturbation is generally found in the presence of 
oligomeric or protofibrillar α-syn, we observe bilayer thinning upon the addition of 
monomeric α-syn.  While the completeness of the stBLM was maintained during the 
course of our experiments (~95% – 100% completeness), it is plausible that measured 
membrane thinning could represent a first step leading to disruption or even 
permeabilization of the bilayer as found under certain solution conditions.   
5.3.3  Using Neutron Reflectometry to Examine the Effects of α-Synuclein 
Concentration on the Protein-membrane Interface  
Elucidating how changes in lipid-to-protein stoichiometry affect protein and 
membrane properties is important because changes in α-syn concentration in the body 
are linked to early-onset PD.72,73  Moreover, α-syn aggregation kinetics are modulated 
by the presence of varying concentrations of lipid vesicles in vitro.117-119  To gain 
insights into the role of membrane-protein stoichiometry in modulating membrane-
bound α-syn structure and membrane properties, NR was performed on a stBLM (1:1 
molar ratio POPA:POPC) in the presence of varying concentrations of α-syn (10 nM 
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− 5μM in 10 mM NaPi, 100 mM NaCl).  For enhanced contrast between the stBLM 
and the protein, uniformly deuterated α-syn was produced and used in these 
experiments (~76% estimated by ESI-MS).  Again, a minimum of two reflectivity 
curves were collected for each condition using isotopically different solvents.   
Prior to NR experiments, the effect of deuteration on α-syn membrane binding 
was assessed by using CD spectroscopy.  Specifically, we compared changes in α-
helical content (change in mean residue ellipticity at 222 nm; Δ[Θ]222nm) of the 
deuterated and protonated protein in the presence of varying concentrations of 
POPA:POPC unilamellar vesicles.  As shown in Figure 5.3, Δ[Θ]222nm for the 
deuterated protein (red) is comparable to that of the protonated protein (black).    
 
 
Figure 5.3  Comparison of membrane induced secondary structure for protonated 
(black) and uniformly deuterated (red) WT α-syn in 10 mM NaPi, 100 mM NaCl, pH 
7.4 buffer with addition of lipid vesicles (1:1 molar ratio POPA:POPC). (Inset) 
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Figure 5.4 shows the neutron reflection for the stBLM alone and in the presence of 
deuterated α-syn (5 μM in 10 mM NaPi, 100 mM NaCl, pH 7.4 H2O buffer).  
Reflectivity curves for the other concentrations tested (10 nM, 50 nM, 250 nM, and 1 
μM) fall within these curves, but have been omitted for clarity.  Once again, 
significant changes in the measured reflectivity upon the addition of protein are 
present and manifest in modulation of the amplitude and the frequency of the Kiessig 
fringes.  Fits of the data based on a composition space model189 are shown as solid 
lines.   
 
Figure 5.4  Neutron reflectivity (R/RF) for a POPA:POPC stBLM in the absence and 
presence of deuterated α-syn (5 μM in 10 mM NaPi, 100 mM NaCl, pH 7.4) in H2O.  
Composition space model fits to the data are shown as solid lines. Error bars 
represent the 68% confidence intervals for the measured reflectivity based on Poisson 
statistics. 
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Using best fits to NR data,189 a cross-sectional profile of the organic interfaces 
at each α-syn concentration was generated.  Simplified molecular distributions for the 
POPA:POPC stBLM in the presence of varying concentrations of α-syn (10 nM – 5 
μM, in 10 mM NaPi, 100 mM NaCl, pH 7.4) are shown in Figure 5.5.  Fit parameters 
extracted from the best fits to the data can be found in Table 5.2.  Prior to incubation 
with protein, substrate and neat bilayer parameters fall within expected values with an 
inner and outer bilayer leaflet thickness of 1.1 21.159.18 −  Å and 
5.2
43.196.14 −  Å, respectively.  
Consistent with previous NR measurements, upon protein addition, membrane-
associated α-syn extends into the hydrocarbon core as well as into the bulk solvent 
region.  Membrane thinning was also observed at all concentrations.  
 
Figure 5.5  Simplified molecular distributions for each of the organic interface layers 
of the POPA:POPC stBLM in the presence of varying concentrations of α-syn (10 nM 












Table 5.2:  Neutron reflectometry fitting parameters for a POPA:POPC stBLM in the 
presence of varying concentrations of α-syn (0 − 5 μM in 10 mM NaPi, 100 mM 
NaCl, pH 7.4).  
 
 
a The 68.2% confidence intervals for each fit parameter are designated in super- and subscripts.  
 
b The high density peptide region is located near substrate-distal headgroups and penetrates into the 
hydrocarbon chains of the bilayer. 
 
c The low density region is located above the outer headgroups and describes peptide which is extended 
into the bulk solvent phase 
 
 
 While not precluding local protein conformational changes, values for 
average α-syn bilayer penetration ( 3.3 0.67.5 −  Å) and extension into the bulk solvent (56 
Å) were consistent for all protein concentrations tested.  However, significant 





10 nM 50 nM 0.25 μM 1  μM 5 μM 
Solid Substrate 
thickness SiOx (Å) 14.68+0.19-0.19 
nSLD SiOx (Å-2) 3.64 × 10-6   (fixed) 
thickness Au (Å) 135.88+0.37-0.38 
nSLD Au (Å-2) 4.303+0.042 -0.042 × 10
-6 
stBLM, Tether Region 
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upon increased α-syn.  Relative trends in volume fraction of α-syn in the 
headgroup/hydrocarbon and bulk solvent region as well as in bilayer thinning are 
provided in Figure 5.6.  In this representation all data are normalized to values for the 
lowest and highest protein concentration to facilitate comparison (for absolute values, 
see Table 5.2).  At 10 nM α-syn, the volume fraction of protein in the 
hydrocarbon/headgroup and bulk solvent region is 057.0 046.0046.0 −  and 
022.0
019.0019.0 − , 
respectively.  As the protein concentration is increased (10 nM – 5 μM), the volume 
fraction in the hydrocarbon and headgroups increases ( 057.0 046.0046.0 −  − 
054.0
077.0117.0 − ) 
though not fully saturating.  In contrast, the volume fraction extending into the bulk 
solvent nearly saturates by 50 nM at a value of 015.0 022.0042.0 −  as compared to 
016.0
022.0046.0 −  
at 5 μM. 
 
Figure 5.6  Comparison of volume fraction of membrane bound α-synuclein 
extending into the bulk solvent (blue) and occupying the headgroup/hydrocarbon 
region (green) as well as the degree of membrane thinning (red) as a function of α-


































Though no direct correlations between membrane thinning and the volume 
fraction of α-syn in the hydrocarbon/headgroup region are present, significant 
membrane thinning is only observed when occupancy in the bulk solvent region 
reaches near saturating values (> 50 nM α-syn).  Since volume occupancy in the 
hydrocarbon/headgroup region continues to increase at concentrations above 50 nM, 
it is plausible that as proteins concentrate at the vesicle surface, sufficient 
neutralization of the anionic membrane ensues promoting a fraction of membrane-
bound proteins into conformations that do not extend into the bulk solvent region.  
Alternatively, as the membrane thins, greater penetration of membrane-bound 
proteins may ensue and manifest in increased occupancy in the 
hydrocarbon/headgroup region.  Regardless of the exact conformations, these data do 
suggest that even small changes in the soluble monomeric α-syn concentration can 
promote membrane thinning.  It is possible that similar small changes in α-syn 
concentration in vivo could also promote membrane permeabilization which has been 
linked to cell toxicity and PD pathogenesis.  
5.4  Summary 
Using NR and A POPC:POPC stBLM, we have examined membrane-bound 
α-syn structure as well as changes in phospholipid bilayer properties resulting from 
protein binding.  We find that α-syn associates with the membrane at both the 
headgroup and hydrocarbon chain region, extends into the bulk solvent, and induces 
membrane thinning.  These data provide the first structural evidence at the molecular 
level for membrane perturbation by monomeric α-syn.  Since changes in α-syn 
concentration have been linked to early-onset PD,72,73 addition NR experiments were 
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performed to examine the effects of lipid-to-protein stoichiometry on protein and 
membrane structure.  In these experiments uniformly deuterated α-syn was used to 
ensure greatest contrast between the protein and the bilayer.  NR data reveal α-syn 
concentration dependent (10 nM – 5 μM) changes in membrane thinning ( 36.0 32.052.0 −  − 
54.0
30.072.1 −  Å) as well as protein volume occupancy in the headgroup/hydrocarbon         
( 057.0 046.0046.0 −  − 
054.0
077.0117.0 − ) and bulk solvent (
022.0
019.0019.0 −  − 
016.0
022.0046.0 − ) regions.   
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Chapter 6:  Effects of pH on Aggregation Kinetics of the 




Though amyloid structure is mostly recognized for its involvement in human 
diseases such as Alzheimer’s and Parkinson’s disease, it is striking to find that 
amyloid fibrils can also serve essential biological roles.8-12  A central question is why 
functional amyloids are benign whereas their disease-related counterparts are not.  
Specifically, it is not clear if functional amyloidogenic proteins are not cytotoxic 
because they circumvent conformationally altered (misfolded) fibrillar precursors 
such as spheres and annuli,14 or because their amyloid formation and degradation are 
efficiently regulated by the cell.  Because such issues remain poorly understood, 
detailed studies on amyloid formation kinetics as well as the solution conditions and 
biomolecules that impact this assembly are required.   
Elucidating the aggregation kinetics and fibrillar structures of the functional 
amyloid, Pmel17, whose fibrils serve as the structural scaffolding required for 
melanin deposition in human skin and eyes, is of particular interest.  Moreover, 
because melanosomes, organelles where Pmel17 fibrils are formed, are acidic 
                                                 
* Adapted from Pfefferkorn, C. M.; McGlinchey, R. P.; Lee, J. C.  Effects of pH on aggregation 
kinetics of the repeat domain of a functional amyloid, Pmel17. Proc. Nat. Acad. Sci. U.S.A. 107 (2010) 
21447 – 21452.  Thanks to Mathew Daniels and Patricia Connelly (Electron Microscopy Core Facility, 





compartments that change pH during maturation, understanding the role of solution 
pH in fibril formation is also of particular interest.193   
 Melanin is synthesized in melanosomes, organelles related to both endosomes 
and lysosomes, and stored in melanocytes, cells responsible for pigmentation.13  The 
rate limiting step in melanin synthesis is catalyzed by tyrosinase.  In this reaction, 
tyrosine is converted to dihydroxyphenylalanine (DOPA) which is then transformed 
to dopaquinone and readily oxidized to 5,6-dihydroxyindole followed by indole-5,6-
quinone.  Melanin is the polymerized product.  Importantly, Pmel17 fibrils have been 
proposed to sequester and detoxify these potent cytotoxic precursors.194  
The melanosome maturation process has been shown to involve four distinct 
stages that have been characterized in detail at the ultrastructural level by TEM.195  
Fibrous structures begin to form in stage I with aggregation completed by stage II.13  
Melanin is produced and deposited during later stages, III and IV.13  While 
melanosome ultrastructure is known, the molecular nature of Pmel17 fibrils and how 
intramelanosomal solution conditions mediate fibril formation remain to be 
elucidated.  Interestingly, it is known that solution pH changes with melanosome 
maturation with early stages I and II being the most acidic and later stages III and IV 
reaching near neutral pH.196,197  The activity of tyrosinase is also pH dependent in 
vitro,198 with the final step in melanin polymerization slowed under acidic 
conditions.199  Tyrosinase enzymatic assay results suggest that melanin synthesis 
indeed is more likely to occur in the mature melanosomes near neutral pH.  Because 
pH mediates melanin synthesis and has been shown to affect the aggregation of 
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disease-related amyloidogenic polypeptides in vitro,8 we suggest that solution pH also 
could influence Pmel17 fibril formation within the melanosome. 
The Pmel17 gene was first discovered in mice in 1930;200 although, it was not 
until 1991 when it was named and mapped to the silver locus.201  Because its over-
expression in non-pigmented cells produces late endosomes exhibiting 
indistinguishable fibrous striations from those found in melanosomes,202 Pmel17 was 
implicated as the main protein component in melanosomal fibrils.  Furthermore, when 
fibrils are not present, mice present a silver genotype, hence corroborating the 
biological function of Pmel17 in normal melanin production.203  The 668-residue 
polypeptide, Pmel17, is composed of a large luminal domain containing several sub-
domains with short C-terminal transmembrane (35 residues) and cytoplasmic 
segments (30 residues).203  Posttranslational proteolytic processing of Pmel17 is 
critical for function producing respective C- and N-terminal fragments, Mβ and 
Mα,204 the latter reported to form amyloid in vitro.194  In vivo, subsequent cleavage of 
Mα results in MαN and MαC, where the C-terminal fragment, MαC is believed to 
contain the fibril-forming region; however, neither the precise sequence of MαN or 
MαC is fully identified.205-208  Though there is no current consensus as to which 
polypeptide domain solely or partly constitutes the amyloid core of the Pmel17 
filaments, recent results have shown that both isolated luminal regions, the repeat 
domain, RPT, residues 315 − 444 (Figure 6.1)209 and the polycystic kidney disease-1 
like domain, residues 201 − 314210 are sufficient for amyloid formation in vitro.  
While both domains are known to be important for fibril formation in vivo,211 RPT is 
used as a model system to study Pmel17 amyloid formation kinetics in this work 
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because prior observation revealed that RPT fibril stability is particularly pH 
sensitive.209  Further, the inability of a closely related, melanosomal glycoprotein, 
NMB, which lacks a RPT domain, to form fibers also points to the role of this 





Figure 6.1 A schematic representation of the N-terminal domain (Mα) of Pmel17 
with the repeat domain (RPT, residues 315 − 444) highlighted. The amino acid 
sequence of RPT is shown with ionizable sidechains in bold. The native fluorophore, 
W423, utilized in this study is underlined. 
 
In this chapter, we investigate the aggregation kinetics and fibrillar structures 
of the crucial polypeptide fragment, the repeat domain (RPT) of Pmel17.  
Specifically, RPT conformational changes from soluble and unstructured monomer to 
aggregated, β-sheet-containing fibrils are monitored.  To mimic the changing acidic 
pH conditions of the maturing melanosome,193,196,213 RPT amyloid formation kinetics 
and the conversion of fibril morphology as a function of solution pH (4 – 7) were 
measured.  Since tryptophan emission is highly sensitive to solvent polarity, local 
conformational changes, and protein-protein interactions,44,59 the only intrinsic 
tryptophan (W423) is exploited as a site-specific fluorescent probe of amyloid 
structure and aggregation kinetics.  W423 is exquisitely sensitive to soluble and 
RPT







fibrillar RPT conformation with spectral properties (integrated intensity (I) and mean 
wavelength <λ>) exhibiting distinct temporal changes under the various solution 
conditions examined.  Complementary techniques, TEM and CD spectroscopy, also 
were employed to characterize fibrillar ultrastructures and secondary structural 
content, respectively.   
6.2  Materials and Methods 
6.2.1  Materials 
N-acetyl-tryptophanamide (NATA) and acrylamide were obtained from Sigma-
Aldrich (St. Louis, MO).   
6.2.2  Protein Expression and Purification 
Protein expression and purification were carried out as previously described 
with the following modification.209  Cell lysis buffer contained 8 M guanidinium 
hydrochloride, 100 mM NaCl, 100 mM K2HPO4, pH 7.5, and 10 mM imidazole.  All 
purified proteins (2 − 6 mg/mL) were stored at 4°C until use.   
6.2.3  Fibril Formation Kinetics and pH Titration 
Purified RPT was filtered through Microcon YM-100 spin filter units 
(MWCO 100kD, Millipore) and exchanged into the appropriate aggregation buffer 
(pH 4.0 − 5.6: 20 mM sodium acetate, 100 mM NaCl, pH 6.0: 20 mM MES, 100 mM 
NaCl and pH 7.0 − 7.3: 20 mM MOPS, 100 mM NaCl) using PD10 (GE Healthcare) 
desalting columns.  The integrity of all protein samples were assessed by SDS-PAGE 
on a Pharmacia Phastsystem (Amersham Biosciences) visualized by silver-staining 
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methods.  All buffers were filtered (0.2 μm).  Final protein solutions (2 − 60 μM, 1.5 
− 2.0 mL) were added to and sealed in screw-cap, quartz cuvettes (10 x 10 mm).  To 
initiate RPT aggregation, the cuvettes were put into an incubating microplate shaker 
(VWR) at 37 ˚C and 600 rpm.   
At various aging times, protein samples (cuvettes) were removed from the 
incubator for measurements of absorption, fluorescence, and laser light scattering. 
Absorption and fluorescence (λex = 280 nm, λobs = 300 − 500 nm, 0.3 s integration 
time, 1 nm bandwidths, 25 °C, a long pass filter (290 nm) was used to minimize 
scattering background) spectra were obtained on a CARY 300 Bio spectrophotometer 
(Varian) and a Fluorolog 3 fluorimeter (Horiba Jobin Yvon), respectively.  To verify 
minimal thermal and/or photodamage (≤ 5% over the course of 1 week, 29 time 
points) and to correct for any emission intensity variations (lamp power) all steady-
state emission spectra were normalized to the emission of a model fluorophore, N-
acetyl-tryptophanamide incubated at 37 °C.  Laser light scattering experiments were 
carried out using a home-built apparatus consisting of a CW laser (λex = 450 nm, 
CrystaLaser) as the excitation source and a photodiode as the detector at a 90° 
geometry.  Scattering intensities (mV) were recorded using a data recorder and 
averaged over a 30-s period while stirring at ambient temperature.  Reported values 









Scattering /=   (6.1), 
where ScatteringNorm is the normalized scattering intensity of the RPT sample, Istd is 
the scattering intensity of a standard (polystyrene beads) sample, and IrefRPT and IrefStd 
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are the intensities from a reference photodiode monitoring laser power for RPT and 
standard scattering sample, respectively.  Dynamic light scattering data were 
collected and correlation times, τc, determined using a Wyatt DynaPro NanoStar (50 
5s acquisitions, 25 °C). 
For pH titration experiments, small amounts (5 − 20 μL) of 1 M sodium 
hydroxide were added to preaggregated samples of RPT at pH 4.0 (1.5 mL, ([RPT]= 
30 μM for 72 h at 37 ˚C, 600 rpm) to raise pH from 4 → 5 and then subsequently 
from pH 5 → 7.  At each pH, a steady-state emission spectrum (uncorrected, dilution 
effects were negligible < 2%) was collected and a TEM grid was prepared after 
equilibrium was reached as evidenced by stabilization of the W423 steady-state 
emission spectrum (within 10 min after NaOH addition, 25°C, stirring). 
6.2.4  Fibril Characterization 
At various aging times, cuvettes containing protein were opened to extract 
samples for ThT binding measurements (133 μL) and for TEM (10 μL).  For ThT 
experiments, protein samples were diluted (6.7 μM final concentration) with freshly 
prepared ThT (20 μM) in appropriate aggregation buffer (vide supra).  ThT samples 
were equilibrated at room temperature and fluorescence measured on a Fluorolog 3 
fluorimeter (Horiba Jobin Yvon) (λex= 400 nm, λobs = 450 − 700 nm, 0.25 s 
integration time, 2 nm bandwidths, 25 °C).  TEM was performed using a JEOL JEM 
1200EX transmission electron microscope (accelerating voltage 80 keV) equipped 
with an AMT XR-60 digital camera (Electron Microscopy Core, NHLBI).  Sample 
grids (400-mesh formvar and carbon coated copper, Electron Microscopy Sciences) 
were glow discharged for 30 s using an EMScope TB500 (Emscope Laboratories) to 
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increase surface hydrophilicity prior to deposition of protein sample (5 μL).  After 1.5 
min, excess sample was absorbed with filter paper and stained by two 
application/wick cycles (30 and 10 s) of 0.5% w/v aqueous uranyl acetate solution. 
Before and after incubation, CD spectroscopy was performed to verify secondary 
structural transitions.  CD spectra were collected on a Jasco J-715 spectropolarimeter 
(205 – 260 nm, 1 nm steps, 1 nm bandwidth, 0.5 s integration time, and 50 nm/min, 
25 °C). 
6.2.5  Time-resolved Fluorescence 
The fourth harmonic (293 nm) of an optical parametric amplifier (Light Conversion) 
pumped by a regeneratively amplified femtosecond Ti:sapphire laser (1 kHz, Clark-
MXR) and a picosecond streak camera (Hamamatsu) were used as the excitation 
source and detector, respectively for time-resolved measurements.  Trp emission (325 
– 400 nm) was selected through using edge (REF-325) and short-pass (UG-11) filters 
(CVI Laser).  For time-resolved anisotropy measurements, polarized Trp (I⊥ and I׀׀, 
325-400 nm) excited-state decays were collected simultaneously with an optical fiber 
array.  Fluorescence anisotropy decays were calculated and analyzed according to the 
following equations (Eq. 6.2 and 6.3, respectively) where r0 is the apparent anisotropy 













=   (6.2) 
)/exp()( 0 ctrtr φ−=   (6.3) 
 109 
 
6.2.6  Tryptophan Quenching  
Tryptophan quenching measurements were made on a Fluorolog 3 fluorimeter 
(Horiba Jobin Yvon; λex = 280 nm, λobs = 300 − 500 nm, 0.3 s integration time, 1 
nm bandwidths, 25 °C) in the presence and absence of increasing amounts of 
acrylamide (0 - 87.5 mM).  Aliquots of an 8 M acrylamide stock solution (deionized 
water, filtered 0.22 μm) were added in increments (< 5 μL) to 1.5 mL samples to 
minimize dilution.  For all experiments, samples were equilibrated for one minute 
while stirring at 25 °C prior to measurement.  Quenching data were analyzed 
according to the Stern-Volmer equation, , where Io and I are the 
fluorescence intensities recorded in absence and presence of acrylamide, Ksv is the 
Stern-Volmer constant, and [Q] is acrylamide concentration.   
6.2.7  pH Titration Data Analysis 











where Ii and λi is the emission intensity and wavelength, respectively, for i = 300 − 
500 nm.  Integrated intensity (I) of W423 emission was determined according to 
trapezoidal integration. Using <λ> data, apparent pKa and the number of ionization 


























where <λ>neutral and <λ>acidic  are the W423 fluorescence mean wavelengths at 
neutral (≥ 6.0) and acidic (≤ 4.0) pH, respectively.  Data fitting and trapezoidal 
integration was performed using IGOR Pro 6.01 (Wavemetrics). 
6.3  Results and Discussion 
6.3.1  RPT Amyloid Structure and Aggregation Kinetics 
The RPT primary amino acid sequence is comprised of 10 imperfect 13 
residue repeats that are rich in proline, serine, threonine, and glutamic acids (Figure 
6.1).  RPT contains 16 carboxylates underscoring its propensity to undergo pH 
induced conformational changes.  Because pH and protein conformation likely are 
linked in vivo (vide supra), we employed TEM, static light scattering, and a ThT 
fluorescence assay214 to determine the effects of pH on RPT amyloid formation 
(Figure 6.2).  As fibril formation processes generally exhibit sigmoidal kinetic 
behavior characterized by a lag, growth, and stationary phase,7 we made frequent 
light scattering measurements during each of these phases.  TEM was used as a probe 
of macroscopic morphology before and during the initial growth phase, and then 
again after aggregation was completed (stationary phase).  As it is typical for amyloid 
formation kinetics, we observed sample-to-sample variations in the lag phase, during 
which time little or no apparent changes in fibril concentration can be detected.215  
However, despite greater uncertainties in the absolute lag times, we ascertained that 
the pH dependent trends (e.g. relative aggregation rates and respective spectroscopic 
signals) as well as corresponding fibril morphologies were comparable and 
reproducible.  Specifically, aggregation kinetics are accelerated from pH 5.5 (20 – 30 
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h) to 4.0 (< 1 h).  We find that fibrils are formed only below pH 6.0, consistent with 
previous observation that RPT fibrils will dissolve in near neutral and basic 
solutions.209  Further, the morphology and homogeneity of fibrils formed at pH 4.0 
and 5.5 are distinctive from each other and apparently more uniform than those 
formed under intermediate pH conditions (4.5 – 5.0).   
 At pH 5.5, aged RPT forms long and homogenous fibrils that have moderate 
ThT fluorescence and light scattering signals (Figure 6.2, top).  TEM images show 
that no oligomers are formed prior to incubation.  At the beginning of the fibril 
growth phase (after 20 – 30 h of incubation at 37 °C and shaking at 600 rpm), a few 
large laterally associated small fibrillar species (~ 70 nm in average length) appear.  
After growth is complete (~ 60 − 100 h), we find primarily straight and long fibrils (> 
1 μm) approximately 18 nm in width reflecting significant restructuring between early 
growth and stationary aggregation phases.      
 





Figure 6.2  pH dependence of RPT aggregation kinetics and amyloid structures. 
Laser light scattering (left), thioflavin T assay (middle), and transmission electron 
microscopy images (right) of RPT (30 μM) as a function of incubation time at 37 °C 
with agitation (600 rpm) in buffers pH 5.5 (top), 5.0 (middle), and 4.0 (bottom) 
buffers (20 mM sodium acetate and 100 mM NaCl). Laser light scattering intensity is 
denoted as Iscatt and integrated intensity of ThT emission of RPT sample and buffer 
alone are denoted as Is and Ib, respectively.  ThT and scattering values are in arbitrary 
units; y-axis range is the same for respective scattering and ThT data. 
 
  
In slightly more acidic environments (pH 5.0 − 4.5), differences in 
aggregation kinetics and fibril morphologies are revealed. Greater light scattering and 
ThT signals are observed as well as increased fibril heterogeneity (Figure 6.2).  By 
the beginning of the growth phase (~ 10 − 15 h) a heterogeneous species appears, 
containing both fibrillar and amorphous structures of varying sizes and shapes.  These 
early aggregates finally give rise to primarily long (> 1 μm) and short (~ 125 nm) 
straight fibers as well as sharply curved fibrous structures (Figure 6.2, right inset).  At 
this intermediate pH, RPT is likely sampling multiple conformations resulting in 
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In contrast, at the most acidic pH examined (4.0) RPT rapidly aggregates (< 1 
h) with large preformed oligomers observed at initial measurement.  While the 
aggregates form immediately, our TEM images show that there is no conversion to 
the longer fibrils over time (Figure 6.2, bottom).  These data indicate that RPT adopts 
a conformation leading to alternative oligomeric structures that preclude fibril 
elongation.  We note that the initial aggregates exhibit a low initial ThT signal that 
increases modestly upon aging (~ 90 h).  This increase suggests that while there are 
no long fibrils, the mature aggregates do contain some amyloid-like features.  While 
CD spectroscopy confirms that all aged samples below pH 6.0 exhibit β-sheet 
secondary structure (Figure 6.3), pH 4.0 samples have a slightly reduced mean 
residue ellipticity below 217 nm, reflecting increased random coil content. 
 
Figure 6.3  Secondary structure of soluble and aged RPT.  Circular dichroism spectra 
for RPT at the beginning (T = 0) and end (T = End; > 80 h) of aggregation 
experiments in different pH buffers (pH 4.0 − 5.5: 20 mM sodium acetate, 100 mM 









































6.3.2  Critical Concentration for RPT Aggregation at pH 5.0 
To determine the critical concentration (concentration below which 
aggregation will not occur) for RPT we examined the aggregation kinetics at pH 5 as 
a function of protein concentration.  At this pH, we find that amyloid can form at 
concentrations as low as 2 μM.  This value likely represents an upper limit given that 
we are at the current detection limit of our light scattering apparatus.  RPT 
aggregation kinetics exhibit protein concentration dependent growth rates with 
similar lag times (Figure 6.4).  Though not precluding concentration dependent lag 
phases at concentrations < 2 μM, these results may reflect an alternative aggregation 
mechanism7,216,217 other than nucleation/polymerization,218 the common mechanism 
for disease-related amyloid formation processes.217  The lack of lag time reduction as 
a function of protein concentration could also indicate that the critical RPT 
concentration is extremely low.  
 
Figure 6.4  Concentration dependence of RPT amyloid formation.  RPT amyloid 
formation kinetics monitored by laser light scattering (λex = 450 nm) for [RPT] = 5 − 
30 μM in 20 mM sodium acetate, 100 mM NaCl buffer, pH 5.0 incubated at 37 °C 
with agitation (600 rpm).  Solid lines serve to guide the readers. 
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6.3.3  W423, a Site-specific Probe of RPT Conformation  
We sought to determine how pH influences local protein conformation by 
fluorescence measurements of the only intrinsic tryptophan in RPT, W423, as a 
function of solution pH.  W423 serves as an excellent structural probe as there are 
two nearby carboxylates and ~40% of the total carboxylates residing in the last two 
repeat domains (Figure 6.1). Prior to thermal incubation (T = 0), we observe 
variations in the steady-state W423 emission as the solution pH is lowered (7 → 4) 
(Figure 6.5). These changes demonstrate that protonation of C-terminal carboxylates 
indeed affect local protein conformation. 
 
 
Figure 6.5.  pH dependence of W423 emission spectra for RPT.  W423 emission 
spectra for RPT (60 μM) in pH 4.0 – 7.3 (red-to-blue respectively) buffers (pH 4.0 – 
5.6: 20 mM sodium acetate, 100 mM NaCl, pH 6.0: 20 mM MES, 100 mM NaCl and 
pH 7.0 – 7.3: 20 mM MOPS, 100 mM NaCl). Inset: Mean wavelength, <λ>, of W423 
for RPT (30 and 60 μM) in various pH buffers. Fit is shown as a solid line. 
 
At neutral pH, W423 emission indicates a solvent-exposed indole with a mean 
wavelength (<λ>) of 362 nm comparable to a model complex, N-acetyl-





































shifts (Table 6.1), with an apparent midpoint transition at pH 4.5. As evidenced by 
TEM (Figure 6.2), spectral blue shifts reflect a more hydrophobic environment for 
W423 as protein-protein contacts ensue at pH 4.0.  
Table 6.1  Spectral properties of soluble vs. fibrillar RPT at different pH  
 
 Solublea Fibrillarb 
pHc <λ> (nm)d Irel (a.u.)e <λ> (nm)d Irel (a.u.)e 
4.0 349 1.19 343 1.41 
4.3 348 1.21 344 1.37 
4.5 354 0.91 344 1.14 
4.7 360 0.86 346 1.20 
5.0 360 0.86 347 0.60 
5.5 361 0.94 352 0.37 
5.6 362 0.85 355 0.44 
6.0 361 0.90 361 0.84 
7.0 361 0.95 362 0.93 
7.2 362 0.92 363 0.93 
 
a Soluble data was collected prior to sample incubation (T = 0).   
b Fibrillar data was collected for all samples after the stationary phase of aggregation had been reached 
for pH 4 - 5.5 (T > 50 h).  No aggregates or fibrils are formed at pH ≥ 6.     
c Buffers: pH 4.0 – 5.6: 20 mM sodium acetate, 100 mM NaCl, pH 6.0: 20 mM MES, 100 mM NaCl 
and pH 7.0 – 7.3: 20 mM MOPS, 100 mM NaCl.    
d Systematic error in Trp423 mean wavelength (λ) is estimated to be ~ ± 1 nm. For cases in which n ≥ 2 
(pH 4.0, 4.5, 5.0, 5.5, 6.0) an average value for <λ> is reported.   
e Integrated intensities (I) are normalized to the emission of a model fluorophore, N-acetyl-tryptophan- 
amide to account for any variations due to lamp power fluctuations.  This relative I, or Irel, is given by 





I = , where sampleI  and NATAI  are the integrated steady state 
emission spectrum of the sample and NATA, respectively.  For cases in which n ≥ 2 (pH 4.0, 4.5, 5.0, 
5.5, 6.0) an average value for I is reported.     
  
W423 also exhibits pH dependent changes in integrated emission intensity, I, 
with a small decrease from pH 7 to 5.5 and a substantial increase from pH 5.5 to 4.0 
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(Figure 6.5).  Trp fluorescence quantum yields are known to be modulated in the 
presence of charged residues, with proximity to positive (negative) charges 
corresponding to quantum yield increase (decrease).52  It is plausible that observed I 
changes could reflect nearby carboxylate protonation states as well as intra- and/or 
interprotein conformational changes.  To shed light on these possibilities, we used 
dynamic light scattering measurements to assess the RPT molecular dimensions as a 
function of pH.  We find that there is a pH dependent global structural change 
(diffusion coefficient for pH 4.0 > 5.0 ~ 6.0) consistent with the presence of larger 
oligomers at pH 4 (Figure 6.6).  These results support that W423 spectroscopic 




Figure 6.6  pH dependence on size of soluble RPT.  (Left) Dynamic light scattering 
autocorrelation curves for RPT at pH 4.0 (red), 5.0 (yellow), and 6.0 (green).  (Right) 
Relative probabilities for correlation times P(τc) of RPT under pH 4.0, 5.0, and 6.0 
buffer conditions.          
 
  Using the Henderson-Hasselbalch equation, we obtain a pKa ~ 4.5 (Figure 
6.5, Inset).  We find the involvement of at least 3 protons (n) in this process (5 






















is reasonable given the close proximity of W423 to several carboxylates (6 total in 
repeat 9 and 10).  CD spectroscopy confirms that for all solutions conditions 
examined, RPT is unstructured with only minor differences below 230 nm (Figure 
6.3) demonstrating the utility of W423 to detect even small changes in solution 
conformations.  
6.3.4  W423, a Site-specific Probe of RPT Amyloid Formation 
Subsequent conformational changes and protein-protein interactions during 
aggregation also were monitored by W423 as a function of incubation time (37°C, 
600 rpm).  The temporal evolution (0 − 90 h) of W423 steady-state fluorescence for 
RPT is shown in Figure 6.7.  At and above pH 6.0, W423 emission is unchanged for 
the duration of the experiment demonstrating that RPT remains unstructured and 
monomeric.  However, for all acidic conditions (< 6.0), distinct and time dependent 
W423 changes in integrated intensity and spectral shifts are observed. Initially, W423 
emission for pH 5.5 is nearly identical to that observed for pH 6.0; however, during 
the growth phase (after ~ 40 − 50 h) I drops dramatically and a spectral blue shift is 
observed (Δ<λ> = 10 nm; 362 → 352 nm).  As the pH is lowered to 5.0, an increased 
blue shift (Δ<λ> = 14 nm; 362 → 348 nm) as well as a moderate decrease in I is 
observed by ~ 20 − 30 h (during growth phase).  Indeed, time-resolved anisotropy 
(Figure 6.8) and acrylamide quenching (Figure 6.9) data confirm that at pH 5.0, 
W423 in the fibrillar state exhibits reduced local mobility and greater solvent 
protection (Ksv (pH 5.0) = 10(1) M
–1; Ksv (NATA) = 34(5) M
-1) as compared to initial 
measurement (Ksv (pH 5.0) = 22(2) M
–1).  Reflecting faster kinetics, W423 in pH 4.5 
solution exhibits a blue shift comparable to that observed at higher pH (Δ<λ> = 13 
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nm; 355 → 342 nm) within the first 10 h of incubation.  In contrast to other 
conditions, at pH 4.5, W423 exhibits a significant I increase with only a small 
decrease after ~ 40 h of incubation.  At the lowest pH, we observed rapid RPT 
oligomerization with a high I and blue shifted spectrum at our earliest measurement (t 
= 15 min).  While W423 emission continues to blue shift and increase in I, spectral 
changes are completed within 5 h.  
 
 
Figure 6.7  W423 emission intensity surfaces as a function of pH (4-to-6, top-to-
bottom).  RPT (30 μM) emission surfaces are plotted as a function of the aggregation 
time (0 − 90 h) and wavelength (300 – 440 nm).  Trp423 emission intensity is in 
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6.3.5  Tryptophan Fluorescence Reflects Fibril Morphologies  
We found correlations between W423 spectral changes and amyloid 
morphology.  In all cases for which a W423 decrease in I is observed (pH 4.5 – 5.5), 
distinct fibrillar species are also present.  Measurements of W423 excited state decays 
are consistent with steady state data showing that the average fluorescence lifetime is 
decreased in the amyloid form for pH 5 (Figure 6.10).  Specifically, decreases in I are 
most pronounced at pH 5.0 – 5.5 and commence during the growth phase when fibrils 
first appear.  Further, at pH 4.5 long fibrils are only present after the small decrease in 
I commences (~ 40 h). Contrastingly, we find an increase rather than a reduction in 
W423 I at pH 4.0 and accordingly no long fibrillar species present.  We suggest that 
this fluorescence signature (I decrease) could be attributable to Trp−Trp stacking, 
possibly resulting from a parallel in-register β-sheet conformation.  We propose this 
fibrillar structure, where corresponding residues of adjacent polypeptides 
(W423−W423) are aligned in individual β-strands, because this is a common feature 
of several amyloidogenic proteins.219,220  While Trp-Trp stacking would explain the 
observed decreases in W423 intensity upon fibril formation, it is also reasonable that 
local molecular interactions and/or changes in environment could facilitate other 





Figure 6.10  pH dependence of time-resolved Trp fluorescence for soluble and 
fibrillar RPT and N-acetyl-L-tryptophanamide (NATA, pH 5.0).  For all experiments, 
[RPT] = 30 μM (pH 4.0 and 5.0, 20 mM sodium acetate, 100 mM NaCl, pH 6.0: 20 
mM MES, 100 mM NaCl).  
 
We attribute the spectral blue shifts and increased I at low pH (< 4.5) to reflect 
an increased hydrophobic local environment upon protein oligomerization.  
Bimolecular acrylamide quenching data (Ksv = 10(1) M
–1
, pH 4.0) are consistent with 
a polypeptide structural rearrangement in which W423 is sequestered from the 
aqueous environment.  Additionally, the I increases in the oligomeric state could 
reflect intra- or interprotein contacts that promote W423 interaction with positively 
charged residues (K378 and R429, Figure 6.1).  We favor R429 because of its closer 
proximity to W423.   
Regardless of the exact nature of these distinguishing spectroscopic features, 
it is clear that W423 is an exquisite probe of RPT amyloid formation and has 
provided kinetic information that is not available from other measurements.  We note 
that while Trp fluorescence has been used to report on the amyloid formation process 
for the disease-related polypeptides α-synuclein221,222 and Aβ1−40,223 large changes in 

























highlights an important role for the C-terminal repeats in RPT fibril growth. 
Supplementary lines of evidence also support that the RPT amyloid core likely 
involves the C-terminal repeats: (1) amyloid-structure destabilizing proline residues 
are found primarily between repeats 1 to 7 and repeat 10;224 (2) in vivo, repeats 2-3 
are known to be heavily O-glycosylated with highly charged sialylated glycans which 
would add steric constraints within the N-terminal domain and therefore less likely to 
contribute to amyloid assembly;205,225 (3) the amyloid sequence predictor Waltz 
indentified 403AEVSIVVL410, located within repeats 7 and 8, as the most 
amyloidogenic sequence.226  
6.4  Implications 
Our data clearly show that solution pH affects both RPT aggregation kinetics 
and fibril morphology with W423 reporting on the local conformational changes 
corresponding to observed ultrastructures. By comparison of equilibrium pH 
dependent W423 data we find that the pKa of aggregated samples is shifted from 4.5 
to 5.5 (Figure 6.11). This shift is reasonable given that it would be more favorable to 
have neutral rather than charged groups buried within the hydrophobic amyloid core. 
Therefore, protonation is facilitated upon aggregation. In contrast to protonation of 
the soluble protein, this process in the fibril involves only one ionizable group rather 







Figure 6.11  Comparison of critical pH regimes for soluble and fibrillar RPT.  Mean 
wavelength, <λ>, of W423 in different pH buffers (pH 4.0 – 5.6: 20 mM sodium 
acetate, 100 mM NaCl, pH 6.0: 20 mM MES, 100 mM NaCl and pH 7.0 – 7.3: 20 
mM MOPS, 100 mM NaCl) of RPT samples at the beginning (T = 0) and end (T = 
end) of aggregation.  Solid lines are fits.  Critical amyloid formation pH is identified 
to be pH 4.5 – 5.5 (shaded area).    
 
Because pH is critical in mediating RPT solution conformation and 
aggregation processes, we hypothesize that the changes in pH that occur during 
melanosome maturation provide one potential natural regulator of Pmel17 amyloid 
formation.  To test this hypothesis, we monitored fibril morphological and local 
polypeptide conformational changes upon pH titration of aggregated RPT from pH 4 
→ 5 → 7 through TEM and W423 fluorescence (Figure 6.12).  In the preformed 
aggregate at pH 4 ([RPT] = 30 μM for 72 h at 37 ˚C, 600 rpm), the Trp indole is 
mostly solvent-protected (<λ> = 343 nm; Ksv = 10(1) M–1).  Upon sequential solution 
neutralization spectral red shifts (343 → 350 → 360 nm) and integrated intensity 
decreases are observed from pH  4 → 5 → 7,  similar to that of the RPT samples 
independently prepared and aged (Figure 6.7).  Interestingly, the observed fibril 
morphological changes from small, indistinct to long, striated fibrils are rapid (< 10 
min, 25 ˚C) and are reminiscent of those observed in stage I (pH 3 − 4) and II (pH 4.6 
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− 5) melanosomes.13,195  Further neutralization to pH 7 results in almost complete 
dissolution of fibrillar RPT, supporting a highly reversible aggregation-
disaggregation process. It is this feature that makes RPT amyloid unique as disease-




Figure 6.12  pH induced RPT fibril morphological conversion and the melanosome 
maturation process.  TEM images (top) of aggregated RPT at pH 4 (20 mM sodium 
acetate, 100 mM NaCl, left), after adjusting the pH to 5 (after 10 min, middle), and to 
7 (after 10 min, right).  Corresponding W423 steady-state emission spectra are shown 
in the inset.  Schematic representation (bottom) of pH dependence of melanosome 
maturation: stage I, protein aggregation is initiated; stage II, fibrils elongate; stages 
III/IV, melanin deposition occurs. 
 
Based on our results, we propose in the highly acidic melanosome (stage I), 
protein aggregation is initiated with fibril elongation occurring only after the 
compartment solution reaches an optimized pH ~ 5 (stage II).  Upon protonation of 
specific carboxylates, the electrostatic charge repulsion within the polypeptide chain 
reduces, thereby leading to formation of compact structures that promote key 
interactions required for fibril formation. In addition, our observation that RPT will 
Melanin Deposition
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readily aggregate (≤ 2 μM) at the optimized pH (5.0) could suggest that only fibrils 
are stabilized in lieu of potentially toxic oligomers.194  While our data show that 
fibrils would dissolve in the near neutral conditions (pH 6 and above) found in stage 
III and IV melanosomes, it is unclear whether upon melanin deposition, the polymeric 
material could sequester the fibrils from solution and hence protect them from 
dissolution.  Nevertheless, if released and exposed to the neutral environments 
outside the melanosome, fibrils will readily disintegrate and thus maintain their 
benign nature in the body.   
6.4  Summary 
We have determined the effects of solution pH (4 → 7), mimicking pH 
conditions of melanosomes, on the solution conformation and aggregation kinetics of 
the RPT domain of Pmel17.  Using intrinsic Trp423 fluorescence, a highly sensitive 
probe of amyloid assembly, we have identified specific spectral features reflecting 
local conformational and macroscopic fibril morphological changes.  A critical pH 
regime (5 ± 0.5) was identified for fibril formation suggesting the involvement of at 
least three carboxylic acids in the structural rearrangement necessary for aggregation.  
Moreover, we demonstrate that RPT fibril morphology can be transformed directly by 
changing solution pH.  Based on these results, we propose that intramelanosomal pH 
regulates Pmel17 amyloid formation and its subsequent dissolution in vivo. 
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Appendix 1: Instrumentation 
A1.1  Time-resolved Fluorescence 
Time-resolved measurements were made using the output of an optical 
parametric amplifier (OPA) (Light Conversion) pumped by a regeneratively 
amplified femtosecond Ti:sapphire laser (1.3 W, 1 kHz, 150 fs, Clark-MXR) and a 
picosecond streak camera (Hamamatsu) for detection.  To ensure monochromatic 
excitation of the sample, aberrant photons are separated from those of the desired 
wavelength by subjecting the OPA output beam to a Pellin Broca prism.  Coarse 
adjustments to excitation power are made using a Berek polarization compensator 
(New Focus) in conjunction with a linear polarizer.  To ensure elimination of 
polarization bias in time-resolved measurements, the linear polarizer is set to the 
“magic angle” condition of 35.25° from vertical.228  Fine power adjustments are made 
with a neutral density filter.  Typical final sample excitation powers are 20 – 150 μW 
(292 nm) for single tryptophan containing samples (5 μM).  Samples contained in 1 
cm pathlength quartz cuvettes are placed in an excitation beam focused behind the 
sample and fluorescence emission collected at 90° geometry using a biconvex lens 
allowing for one to one imaging of the excitation volume onto an optical fiber array.  
A schematic representation of the time-resolved instrumental setup is provided in 





Figure A1.1:  Schematic representation of the femtosecond Ti:Sapphire and streak 
camera setup used to measure time-resolved fluorescence and anisotropy decays.  
 
Emission is focused on the entrance slit of the streak camera which spatially 
and temporally separates the photons (Figure A1.2).  Briefly, incident photons are 
converted to electrons at the photocathode.  The electrons are then accelerated in-
between a pair of high voltage sweep electrodes.  The voltage gradient across the 
electrodes causes deflections in the electrons proportional to the time and location in 
which electrons entered the voltage gradient.  The spatially and temporally resolved 
electrons then enter a multichannel plate (MCP) where they are enhanced and imaged 
on a phosphor screen.  An example digitized streak image used for data analysis is 
provided in Figure A1.3 (left).  These 3D images contain information regarding the 





























coordinate to generate 2D (intensity vs. time) fluorescence decay curves (Figure A1.3, 
right).  For time-resolved data collection, the streak camera is operated in single shot 
mode with parameters for single tryptophan containing samples (5 μM) set as 
follows: threshold = 300, 111 ms exposure time, 2000 – 5000 exposures.  At these 
settings, the highest emission intensity is between 3% – 5% above threshold.      
        
 
Figure A1.2:  Schematic representation of the streak camera. 
 
 
Figure A1.3:  An image of the emission of a fluorescent protein sample generated by 
the streak camera (left).  By binning data in the spatial coordinate, a 2D (intensity vs. 




































Streak Image Time-resolved Fluorescence Decay
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To ensure synchronization of the camera voltage sweep with sample 
excitation pulses, an optical trigger is used.  Under the conditions used for 
experiments (single shot mode), the camera only accepts a sample excitation pulse 
after a trigger signal is received.  The camera resets and accepts subsequent trigger 
pulses at a 1kHz repetition rate using the sync out signal from the Ti:Sapphire laser.  
The output of the fiber laser used to seed the regenerativly amplified Ti:Sapphire 
(1550 nm, 48MHz) is exploited as the optical trigger (Figure A1.1).  Because the 
fiber laser and sample excitation pulses are coupled, one can finely tune the 
respective time between the start of the camera sweep and the time of the incident 
sample pulse by changing the relative delay between the trigger and sample excitation 
pulses.  One method to make this adjustment is by using an optical delay line (i.e. 
increasing or decreasing the distance the trigger pulse travels).  For example, since 
the speed of light is 3.0 × 108 m/s, adding an additional 1 m to the optical path of the 
trigger beam would result in pulses shifted approximately 3.3 ns. 
A1.2  Time-resolved Fluorescence Anisotropy 
To calculate fluorescence anisotropy, a sample must be excited with vertically 
polarized light and the vertical and horizontal components of the fluorescence 
emission measured.  Selection of vertical excitation light can easily be achieved by 
adjusting the linear polarizer adjacent to the Berek polarization compensator to the 
vertical position (θ = 0°) (Figure A1.1).  Vertical and horizontal components of 
emission can be simultaneously measured by exploiting the unique ability of the 
streak camera to collect time-resolved information in the spatial dimension (vide 
supra).  Specifically, the optical fiber array consists of individual optical fibers (100 
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μm) aligned linearly across a 1 cm length.  By placing two linear polarizers (vertical, 
θ = 0°; horizontal, θ = 90°) in front of the optical fiber array, simultaneous vertical 
and horizontal fluorescence decays can be collected (Figure A1.4, left).  An example 
streak camera image of anisotropy data is provided in Figure A1.4 (right).  To correct 
for any differences in the collection efficiency between horizontal and vertical 
components, all data are normalized to the decays of the Trp model complex, N-
acetyl-tryptophanamide (NATA).  For tryptophan anisotropy measurements of singly 
labeled tryptophan proteins (5 μM), sample excitation power is usually 100 – 300 μW 
(292 nm) with streak camera parameters set as follows: threshold = 300, 111 ms 
exposure time, and 5 sequences of 2500 exposures collected.                 
 
 
Figure A1.4:  Time-resolved anisotropy data collection.  (Left)  A schematic 
representation of the two linear polarizers placed before the optical fiber array used to 
collect simultaneous vertical and horizontal components of the emission.  (Right) An 
example image generated by the streak camera of anisotropy data.   
 
A1.3  Static Light Scattering 
A homebuilt static laser light scattering instrument is used to monitor 
macroscopic protein aggregate formation.  The apparatus consists of a fiber coupled 
CW laser (λex = 450 nm, CrystaLaser) as the excitation source and a photodiode as 















data recorder (PicoScope 2205 oscilloscope) and averaged over a 30-s period while 
stirring at ambient temperature.  Sample intensities are normalized to a standard 
scattering sample (polystyrene beads) as well to laser power as measured by a 
reference photodiode.  A schematic of the instrumental set up is provided in Figure 




Figure A1.5:  Schematic representation of the static light scattering instrument used 
















Appendix 2:  Preparation and Characterization of 
Membrane Mimics 
 
A2.1  Preparation of POPA:POPC Liposomes 
Stock solutions of 16:0-18:1 PC and PA (25 mg/mL) dissolved in chloroform 
were purchased from Avanti Polar Lipids (see Figure A2.1 for structure of lipids).  
Molar mixtures (1:1) of POPA:POPC were prepared gravimetrically by combining 
the proper amount of POPA and POPC in a glass vial.*  Individual lipid aliquots 
(0.640 g; 0.432 mL) in glass vials (outer diameter × height; 23 × 85 mm) were then 
prepared and used immediately or purged with argon, sealed, parafilmed, and stored 
at −20 °C for later use.   
 
Figure A2.1:  Structure of POPC and POPA lipids.  
 
 
For preparation of unilamellar liposomes, lipids in chloroform were 
dehydrated under a nitrogen stream. Vials were first sealed with a rubber septum 
containing two needles, one connected to a nitrogen line and one for venting.  As 
nitrogen is introduced to the lipid solution, the vial must be continuously rotated until 
                                                 
* Molecular weight of POPA and POPC is 696.9 and 760.1, respectively.  In determination of the 
amount of POPA and POPC for a 1:1 molar mixture, all gravimetric measurements must take into 
account that lipids are dissolved in chloroform (density = 1.48 g/cm3 at 20 °C).  Lipids dissolved in 
chloroform should not come in contact with plastic.  Glass micropipettes and vials are always used for 
gravimetric measurements and lipid storage, respectively.    
16:0-18:1 PC (POPC), Neutral 16:0-18:1 PA (POPA), Negative
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a uniform lipid film forms on the bottom of the vial.  After 20 min under the argon 
stream, complete removal of the organic solvent is ensured by vacuum desiccation for 
45 min.  Dried lipids are rehydrated with 2.185 mL of desired buffer (5 mg/mL lipid) 
and re-suspended using a water bath sonicator (<10 min).  Probe sonication is then 
performed using a Branson 450 Sonifier equipped with a micro-tip (45 min, duty 
cycle 50%, micro-tip limit).*  After sonication, vesicles are diluted to 2.5 mg/mL with 
2.185 mL buffer.  Liposomes are equilibrated overnight in a water bath above the 
transition temperature of the lipid mixture (−2 °C and 28 °C for POPC and POPA 
respectively).  Before use, liposomes are centrifuged (10 min, 10,000 × g) to ensure 
removal of any titanium dust resulting from probe sonication.  
A2.2  Characterization of 1:1 POPA:POPC Liposomes 
Liposome concentration and size was confirmed using the Bartlett 
concentration assay, and transmission electron microscopy (TEM) and dynamic light 
scattering (DLS), respectively.  In the Bartlett assay, phospholipids are converted to 
inorganic phosphate, phospho-molybdic acid, and then to 4-amino-2-naphthyl-4-
sulfonic acid which can be colormetrically assayed and correlated to the original 
phospholipid content.158  Using this assay, it was determined that no significant loss 
of lipids occurred as a result of probe sonication and subsequent centrifugation.  
Using TEM and DLS, the size distribution of liposome vesicles was evaluated.  An 
example TEM image of POPA:POPC lipid vesicles is provided in Figure A2.2.  It 
                                                 
*The microtip probe should be thoroughly cleaned with soap, rinsed with deionized water, and 
completely dry before use. The micro-tip should be centered in the center of the vial and in the middle 
of the lipid solution (not touching any part of the vial).  The top of the vial should be covered with 
aluminum foil to prevent any spilling of the lipid solution during sonication.  The lipsome vial should 
be placed in a warm water bath during sonciation.  
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was confirmed that the vesicles were unilamellar (TEM) and had average 
hydrodynamic radii of ~100 nm in diameter (DLS).   
 
Figure A2.2:  Characterization of 1:1 POPA:POPC lipid vesicles by TEM. 
 
A2.3  Preparation of Purified Synaptic Vesicles  
Steady-state and time-resolved fluorescence experiments were also conducted 
using purified mouse synaptic vesicles as model membranes.  Synaptic vesicles were 
harvested from mouse brains and purified (synaptic vesicles isolation kit; Sigma 
Aldrich).  Briefly, freshly dissected whole mice brains were weighed and placed in 
Hank’s balanced salt solution buffer (HBSS) for immediate use.  Brains were then 
subjected to a series of homogenization and centrifugation steps to achieve a crude 
vesicle preparation.  To further enrich the synaptic vesicles, ultracentrifugation was 
performed in the presence of a density gradient medium (OptiPrep density gradient 
medium, Sigma Aldrich).  A flow chart summarizing the purification protocol is 
provided in Figure A2.3.  For all experiments, the enriched synaptic vesicles were 
used.  Synaptic vesicles were exchanged into appropriate buffer using PD10 columns 







Figure A2.3:  Flow chart for synaptic vesicles purification.*  
 
A2.4  Characterization of Purified Synaptic Vesicles   
To confirm the presence of and to characterize properties of purified synaptic 
vesicles, an immunoblotting assay and TEM was performed, respectively.  Synaptic 
vesicles, unlike other cellular membranes, contain the membrane protein 
synaptophysin.  Therefore the detection of synaptophysin is an indicator of synaptic 
vesicles.  Figure A2.4 shows a SDS-PAGE gel and subsequent western blot for 
synaptophysin of the purified synaptic vesicle fraction along with several fractions 
from purification steps.  It is clear that synaptophysin is present in the enriched 
synaptic vesicle fraction used for experiments.  
                                                 
*Flow chart modified from the synaptic vesicle isolation kit technical bulletin (catalog number 
SV0100, Sigma Aldrich).    
Homogenize brain 
tissue 
Low speed spin (1,500 
x g) to remove tissue 
debris (collect 
supernatant) 
Medium speed spin 
(20,000 x g) to pellet 
intact and lysed
synaptosomes
Homogenize pellet to 
release synaptic 
vesicles 
Medium speed spin 
(20,000 x g) to remove 
synaptosome debris 
(collect supernatant)
High speed spin 
(70,000 x g) to pellet 
synaptic vesicles










Figure A2.4:  Confirmation of synaptic vesicle presence.  Image of coomassie stained 
SDS-PAGE gel (left) and corresponding western blot for synaptophysin (right) used 
to confirm the presence of synaptic vesicles in various fractions during purification 
and enrichment.  Lanes corresponding to crude purification and OptiPrep enrichment 
of synaptic vesicles are denoted for reference.   
 
To characterize the size and homogeneity of the vesicles, purified synaptic 
vesicles were visualized with TEM.  As seen in the TEM image in Figure A2.5, 
vesicles are highly homogeneous and are approximately 50 – 75 nm in diameter.  It is 
also apparent from the TEM image that several peripheral membrane proteins 





















Figure A2.5:  TEM visualization of synaptic vesicles. TEM image of negatively 





Appendix 3:  Preparation and Characterization of Dye 
Labeled α-Synuclein* 
 
A3.1 Incorporation of Single Cysteine Mutations into α-Synuclein 
Site-directed mutagenesis to incorporate single cysteine residues at desired 
extrinsic fluorophore labeling sites in α-syn was accomplished by using the 
appropriate primers and template plasmid and a quick-change site-directed 
mutagenesis kit (Stratagene).  Appropriate forward and reverse primers were 
designed such that at least 12 wild-type bases (coding 4 amino acids) flank the 
desired cysteine mutation site.  For example, the primers used generate α-syn protein 
containing a G93C mutation are provided in Figure A3.1.  Wild-type human α-syn 
(pRK 172) was used as the template plasmid.84  
 
 
Figure A3.1:  Primer design for G93C α-synuclein.   
 
Components of polymerase chain reaction (PCR) mixtures are listed below in 
order of addition; all reagents were kept on ice prior to mixing.       
H2O to a volume of 20 μL  
2 μL   10x buffer 
25 – 50 ng  wild-type α-syn plasmid    
                                                 
*Single extrinsic 1,5-IAEDANS or IANBD fluorophore labeled α-synucleins were used in fluorescence 
energy transfer, synaptic vesicle, and α-syn aggregation experiments.  Results regarding α-syn 
aggregation experiments are reported in the following publication: Yap, T.L., Pfefferkorn, C. M., Lee 
J.C., Residue-specific fluorescent probes of α-synuclein: Detection of early events at the N- and C-
termini during fibril assembly. Biochemistry 2011, 50(12), 1963-1965.  
α-Synuclein Amino Acid Sequence
Forward Primer
Reverse Primer
A    A A T    C F    V    K    K
5’ GCA  GCA GCC  ACT  TGC TTT  GTC  AAA  AAG 3’ 




50 ng   Forward primer 
50 ng   Reverse primer  
0.4 μL  5 mM deoxyribonucleotide triphosphate (dNTP) 
0.4 μL  PfuTurbo (polymerase) 
  
PCR mixtures were then subjected to thermal cycling as outlined below:  
Step 1    95 °C  4 min 
 
Step 2  (18 cycles) 94 °C  1 min 
   55 °C  1 min 30 seconds 
72 °C  7 min 
 
Step 3   72 °C  10 min 
 
This procedure facilitates the denaturation of the template plasmid, the annealing of 
mutagenic primers, and the extension of primers to form double stranded DNA in 
which one strand contains the mutated sequence.  Nicks in the mutated strand are 
sealed by components in the PfuTurbo enzyme blend.  After thermal cycling, any 
remaining wild-type template plasmid is digested by adding the restriction 
endonuclease DpnI (1 μL; 20 U/μL) to the reaction mixtures and incubating (1 h, 37 
°C and 20 min, 80 °C).   
For purification, PCR DNA products were transformed into XL1-Blue 
competent cells, grown in Luria Broth (LB) media containing Ampicillin (AMP) (100 
μg/μL), and treated using the QIAprep Miniprep Kit (Qiagen).  Briefly, for 
transformation, DNA (1 μl) was added to gently thawed XL1-blue cells (50 μL) in 
pre-chilled PCR tubes and incubated on ice for 5 min followed by a heat shock (45 s, 
42 °C).  Growth medium (200 μL LB) was then added to the DNA/cell mixture, 
incubated (1 h, 37 °C), and spread onto LB agar plates containing AMP (100 μg/mL).  
After incubation (overnight, 37 °C), single colonies were added to 5 mL of growth 
media (LB containing 100 μg/μL AMP) and incubated (shaking overnight, 37 °C).  
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Cultures were centrifuged and cell pellets treated according to protocols found in the 
QIAprep Miniprep Kit.  Purified DNA concentration was measured using absorption 
spectroscopy (OD260nm = 1 = 50 μg/μL).  Mutations were verified by DNA sequencing 
(Macrogen, USA).   
A3.2 Dye Labeling and Purification of Single Cysteine Containing α-Synucleins 
Single cysteine containing proteins were expressed84,159 and purified102 as 
previously reported with minor modifications.  To prevent disulfide bond formation, 
all lysis and purification buffers contained 0.5 mM dithiothreitol (DTT).  Protein 
purity was assessed by SDS-PAGE on a Pharmacia Phastsystem (GE Healthcare) and 
visualized by silver staining methods.  All purified proteins were concentrated using 
Amicon YM-3 (MWCO 3kD, Millipore) and stored at −80 °C.  
Labeling of purified single cysteine containing α-syn with 1,5-IAEDANS, 5-
((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid (1,5-IAEDANS) or 
N,N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine 
(IANBD) (Figure A3.2) is accomplished by forming a thioether bond to the thiol 
group of the cysteine.  First, tris(2-carboxyethyl)phosphine, TCEP (70 μl of 100 
mM), is added to purified protein (14 mL of 50 μM protein in 100 mM NaPi, pH 7.4) 
and incubated (1 h) to ensure complete reduction of any disulfide bonds.  Dye is then 
added dropwise to the reaction mixture (1.5 mL of 5 mM dye prepared in dimethyl-
sulfoxide (DMSO)) and incubated (2 h).  The labeling reaction is stopped by the 
addition of DTT (1 mM).  All reactions were performed in a three neck flask under 
nitrogen flow while stirring and protected from light.  
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Figure A3.2:  Structure of 1,5-IAEDANS (left) and IANBD amide (right). 
 
The dye labeled proteins were then exchanged into the appropriate buffer (20 
mM Tris, pH 8.0) and separated from excess dye using a desalting column (HiPrep 
Desalting 26/10, GE Healthcare).  The singly-labeled α-syn was then purified by 
anionic exchange chromatography using a linear gradient from 100 – 300 mM NaCl 
in 20 mM Tris buffer (MonoQ column, GE Healthcare).  An example chromatogram 
from purification of G7C 1,5-IAEDANS labeled α-syn is provided in Figure A3.3.  
Peaks corresponding to single, double, and unlabeled protein can be identified based 
on absorbance.  Unlabeled protein elutes with primarily 280 nm absorbance, while 
single and double dye labeled α-synucleins exhibit sizable absorbance at other 
wavelengths (1,5-IAEDANS: ε336nm= 5700 M−1cm−1; IANBD: ε478nm= 25,000 
M−1cm−1).  Purified α-syn fractions are concentrated using Amicon YM-3 (MWCO 
3kD, Millipore).  Concentrated and purified singly labeled 1,5-IAEDANS α-syn will 
exhibit a absorbance ratio (OD336 nm/OD280 nm) of approximately 0.8 – 0.9 whereas 
IANBD α-syn will exhibit a absorbance ratio (OD478 nm/OD280 nm) of approximately 
0.4 – 0.6.  Protein purity is assessed by SDS-PAGE on a Pharmacia Phastsystem (GE 
Healthcare) and visualized by silver staining methods.  An example protein gel 
showing purified singly labeled 1,5-IAEDANS G7C α-syn fractions is provided in 
 
 
Figure A3.4.  ESI-MS was a
proteins.   
Figure A3.3:  Anionic-exchan
labeled G7C α-synuclein.  Pre
absorbance peaks at 280 nm 
gradient is indicated in red.      
   
Figure A3.4:  Silver stained 
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